THE MEDICAL COLLEGE OF
VIRGINIA QUARTERLY
The publication of this journal begins at a time
when most physicians already are unable to cope
with the fast-growing medical literature. Our aim
is not to burden them further, but to serve, at
least some, in a different way.
First, the QUARTERLY will publish selected
proceedings of symposiums, seminars, and guest
lectures held at the medical school; material presented at such occasions is often not printed elsewhere. Second, the QUARTERLY will report on
new and exciting developments in research and
teaching at this school. This feature of the journal
is directed primarily to our alumni and friends
everywhere, but we trust will occasionally interest
and enlighten others as well. Third, the QUARTERLY will provide a means for the relatively
quick dissemination of scientific information from
all sources, including results of work that is still
in progress or has not been completely accepted.
Finally, believing that no journal-even a scientific one-need be dull or drab, we will attempt
to present the material in an attractive, if at times
unconventional, format.
In a recent article (New Engl. J. Med. 271:
1249-1251, 1964), Dr. Joseph Garland discusses
the special functions that medical journals can
fulfill in the continuing education of the student
and physician. We hope the QUARTERLY will
contribute a small share.
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COVER
Detail ofpalm leaf design at base and head of columns
flanking entrance to Egyptian Building.

OPPOSITE
The Egyptian Building, first permanent building of the
Medical College of Virginia. Architect: Thomas S.
Stewart, Philadelphia. Completed, 1845 and remodeled,
1939. Stewart was in Richmond to plan and erect St.
Paul's Church. Dr. A . L. Warner, dean and professor of
surgery and surgical anatomy (1807-1847), asked him
to build an anatomy laboratory-a "house of the
dead." The Richmond Times and Compiler (1845)
commented, "there is a mystery in the spirit of the
Egyptian style of Architecture, which makes it to our
taste singularly appropriate for this temple of the
medical science." Perhaps another factor in Stewart's
choice of Egyptian style was the influence of Napoleon's campaigns in Egypt on the French school of
architecture and, in turn , on young American architects.
The Egyptian Building was reconstructed and restored through the generosity of Mr . Bernard M.
Baruch, and its auditorium was dedicated to the memory
of his father, Dr. Simon Baruch (1840- 1921), an
alumnus, class of 1862.
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')'-Guanidinobutyric Acid: An Inhibitor of
Clot Formation and of Clot Lysis*
PHYLLIS S. ROBERTS

Department of Medicine, Medical College of Virginia, Richmond

During a study of the effects of a
series of guanidine compounds on the
esterolytic activities of thrombin, plasmin, and streptokinase plus plasmin or
plasminogen, it was found that one of
these compounds, y-guanidinobutyric
acid (GGBA), acted in several ways
like e-aminocaproic acid (EACA).
Neither compound had any inhibiting
effects on the rate of hydrolysis
of TAMe (p-toluenesulfonyl-L-arginine
methyl ester), but both inhibited the
activation of plasminogen by streptokinase. EACA was the more potent inhibitor. Since EACA has been shown
to inhibit the lysis of fibrin, primarily
because it inhibits the activation of
plasminogen (Ablondi et al. , 1959,
Alkjaersig, Fletcher, and Sherry,
1959), GGBA was tested to see if it,
too, would inhibit the lysis of blood
clots. It was found to do so. In addition, it was found that GGBA also inhibits the formation of blood clots,
which EACA does not do. These preliminary results are reported here.
Materials and Methods

Fresh citrated blood from normal
donors was used. Plasma was obtained
by centrifuging the blood for 20 minutes at 2,500 rpm and 5°C. The euglobulin fraction of the plasma was
precipitated by diluting the plasma
with distilled water (1 part plasma, 14
parts water) and was brought to pH
5.35 with 0.1 N HCI. After centrifugation for 3 minutes at 1,500 rpm and
5 °C, the supernatant was discarded and
the precipitate was dissolved in a barbital-saline buffer, pH 7.35 (Wintrobe,
1961). It was tested immediately for
clot formation and clot lysis.
The contents of a vial of thrombin,
(Thrombin Topical, bovine, Parke,
Davis & Co., 1,000 NIH units) were

* Supported by U. S. Public Health
Service Research Grant HE-04016, from
the National Heart Institute.
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dissolved in 12.5 ml of glycerol and
12.5 ml of 1.8% NaCl and refrigerated. Just before use the stock solution
was diluted with 0.9% NaCl to contain 2 or 4 NIH units per ml. Distilled
water (4.0 ml) was added to a vial
containing 100,000 units of streptokinase (Varidase). Immediately before
use it was diluted with 0.9% NaCl to
contain either 1,000 or 2,000 units per
ml. EACA was purchased from Mann
Research Laboratories, and GGBA
from Calbiochem. A 0.1 M solution of
each compound was prepared in 0.9%
NaCl.
Results

With the blood and plasma from
four donors, inhibition of clot lysis was
shown in the following way. To test
tubes containing 0.1 ml of blood or
plasma from a single donor, 0.1 ml of
thrombin (4 NIH units per ml) was
added and the contents were mixed. A
clot formed immediately in each tube.
After 15 minutes at room temperature
(22-25 °C), the following solutions
were added to duplicate tubes: (1) 0.3
ml of saline (0.9 % NaCl), (2) 0.2 ml
of saline plus 0.1 ml of EACA (0.1 M),
(3) 0.2 ml of saline plus 0.1 ml of
GGBA (0.1 M), (4) 0.2 ml of saline,
15 minutes later 0.1 ml of streptokinase (100 units per ml), (5) 0.1 ml of
saline plus 0.1 ml of EACA (0.1 M),
15 minutes later 0.1 ml of streptokinase (1,000 units per ml), and (6) 0.1
ml of saline plus 0.1 ml of GGBA (0.1
M), 15 minutes later 0.1 ml of streptokinase (1,000 units per ml).
None of the clots in the first three
sets of tubes lysed, even after remaining at room temperature overnight.
The clots in tubes (4) were completely
or partially lysed in a few hours, and
were completely lysed the next morning. The clots in tubes (5) and (6) we;e
not lysed and apparently were completely intact when examined the next
morning.

When the experiments, as outlined
in (4), (5), and (6), were repeated with
either double the concentration of
streptokinase or double the concentration of EACA or GGBA, the same results were obtained. There was lysis
in tubes (4) and no lysis in tubes (5)
or (6).
Inhibition of clot formation was
shown, with whole blood from two
donors. To test tubes containing 0.1 ml
of blood from a single donor were
added: (1) 0.3 ml of saline, (2) 0.2 ml
of saline plus 0.1 ml of EACA (0.1
M), or (3) 0.2 ml of saline plus 0.1 ml
of GGBA (0.1 M). After 15 minutes,
0.1 ml of thrombin (4 NIH units per
ml) was added to each tube. Four minutes later firm clots were present in all
tubes containing saline or saline plus
EACA. No clots were observed in any
of the tubes containing GGBA. After
20 minutes, an additional 0.1 ml of
thrombin was added to the tubes containing GGBA. Clots formed immediately. Firm clots were still present the
following day in all tubes.
A combined clotting and lysing experiment was performed on the euglobulin fraction of the plasma from
two donors. The euglobulin precipitate was dissolved in 0.3 ml of buffered saline. To duplicate tubes (controls), 0.1 ml of saline was added. To
other tubes, 0.1 ml EACA (0.1 M) or
GGBA (0.1 M) was added. Thrombin,
0.1 ml (2 units per ml) was added to
each tube and the tubes were placed in
a 37°C bath. After 15 minutes, firm
clots were present in the control tubes
and in the tubes containing EACA, but
no clots were present in the tubes containing GGBA. After 60 minutes, however, the latter tubes also contained
clots. No evidence of lysis of any of
the clots was seen even after the tubes
had remained at 37°C for 5 hours. The
tubes were then left at room temperature. The next morning no clots were
found in the control tubes, but clots

still remained in the tubes containing
either EACA or GGBA.
Discussion

Low concentrations of GGBA are
widely distributed in mammalian urine,
brain, liver, and other tissues (Pisano,
Abraham, and Udenfriend, 1963).
These authors estimate that 0.05 and
0.09 µ,moles of GGBA, respectively,
are present in 1 gm, fresh weight, of
rat brain and liver. GGBA has been
reported to be of very low toxicity in
rabbits, rats, and guinea pigs (Kamiya,
Kiyota, and Kita, 1962). The finding
that it inhibits the formation as well as
the lysis of clots in the test tube suggests that a guanidine-containing compound may be involved in the physiological regulation of blood clotting and
lysing. GGBA itself is probably not
the compound because it is not potent
enough, judged from the preliminary
experiments in vitro. Possibly a peptide (or peptides), which is released
when fibrinogen is changed to fibrin,
may be the physiological regulating
compound.
From these and other data, it seems
that GGBA may inhibit the hydrolysis
of fibrinogen by thrombin, and in this
way inhibit clot formation. EACA, on
the other hand, has no effect on the action of thrombin and therefore does
not inhibit clot formation. In addition,
both GGBA and EACA may react reversibly with plasminogen, changing it
to a compound that cannot be activated to plasmin. In this way both
compounds inhibit the lysis of clots.
Experiments are now being done
both in vitro and in vivo to establish
quantitatively the extent of the inhibition of clot formation and lysis due to
GGBA. Nagamatsu et al. (1963) have
shown that esters of EACA are more
potent inhibitors of clot lysis than is
EACA itself. It is possible that esters
of GGBA may also be more potent
than GGBA as inhibitors of clot lysis

and clot formation. These compounds
or related ones may prove to be of
value in preventing the formation of
blood clots as well as controlling excessive fibrinolytic activity in vivo.
Summary

y-Guanidinobutyric acid inhibited
the formation and the lysis of clots
made from whole blood, plasma, or the
euglobulin fraction of the plasma from
several donors. e-Amino-caproic acid
inhibited only the lysis of these clots.
not their formation.
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The Effect of ')"-Guanidinobutyric Acid on
the Clotting Time of Normal Plasma
and on the Euglobulin Lysis Time
of Fibrinolytica lly Active Plasma*
LYMAN M. FISHER, PHYLLIS S. ROBERTS, AND WARNER E. BRAXTON

Division of Clinical Pathology, Department of Pathology, and Department of
Medicine, Medical College of Virginia , Richmond
It has been established that e-aminocaproic acid (BACA) inhibits the acof human
plasminogen
tivation
(Ablondi et al., 1959 ; Alkjaersig,
Fletcher, and Sherry, 1959). Because
of this observation, this compound has
been used extensively to inhibit the
pathologically occurring fibrinolytic
system in patients. Recently Roberts
(1965) reported that another compound,
y-guanidinobutyric
acid
(GGBA), like BACA, inhibits the
lysis of human blood clots. Furthermore, GGBA, unlike BACA, retards
the formation of these clots.
The present investigation was undertaken to determine whether GGBA
inhibits clot formation in the onestage prothrombin and in the partial
thromboplastin time tests. In addition,
the ability of GGBA to inhibit clot
lysis was tested using blood from a
patient showing active fibrinolysis.

Materials and Methods

Blood was collected in a 3.8 % sodium citrate anticoagulant (9 parts
blood, 1 part citrate) from 15 individuals. The blood was centrifuged at
2,500 rpm in an angle centrifuge for
10 minutes to obtain the plasma. Clotting tests were performed in duplicate
in glass test tubes (10 X 75 mm. at
37° C . Solutions of BACA (Mann Research Laboratories, New York, N.Y.)
and GGBA (Calbiochem, Los Angeles,
Calif.) were prepared, each having a
concentration of 0.1 M in physiological saline. The pH of the BACA solution was 7.02 and that of the GGBA
solution was 7.03.

* Supported in part by U. S. Public
Health Service Research Grant HE
05868:3640 and HE 04016 from the National Institutes of Health, and by the
Charlotte County (Va.) United Fund, Inc.
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The clotting tests were performed
in the following manner.
1. One-stage prothrombin time: 0.1
ml of plasma; 0.1 ml of either physiological saline (control), 0.1 M BACA,
or 0.1 M GGBA; 0.2 ml of equal
volumes of thromboplastin and CaCl2
(0.025 M). The time taken for clot
formation was measured.
2. Partial thromboplastin time: 0.1
ml of plasma; 0.1 ml of either physiological saline (control), 0.1 M BACA,
or 0.1 M GGBA; 0.1 ml of Thrombofax (Ortho Research Foundation, Raritan, N.J.). The mixture was incubated
for 30 seconds, and then 0.1 ml of
CaCl2 (0.025 M) was added. The tubes
were removed from the water bath after incubation for 60 seconds, wiped
dry, tilted, and the time taken for clot
formation was measured.
The euglobulin lysis time was performed as outlined by von Kaulla and
Schultz (1958), except that 0.1 ml of
either physiological saline, 0.1 M
BACA, or 0.1 M GGBA was added
to the euglobulin precipitate.
Results and Discussion

The effects of BACA and GGBA
on the clotting systems are shown in
table 1.
There was no significant difference
between the values obtained with the
one-stage test for the samples containing saline or BACA. The values obtained when GGBA was added, however, were significantly prolonged (p
< 0.001) when compared with the saline
control.
The findings for the partial thromboplastin test were similar to those
obtained for the one-stage test. GGBA
significantly prolonged the clotting
time when compared with the samples
containing either saline or BACA (p
< 0.01).

Opportunity to test the usefulness
of GGBA in a clinical situation presented itself when a 23-year-old Negro female, gravida 5, para 3, abortus
l, delivered unattended at home a
stillborn term infant. Vaginal bleeding
was profuse, and a physician was
called. When the latter noted that the
blood failed to clot, the patient was
transferred to the Medical College of
Virginia Hospital, arriving in a state
of shock. Numerous blood samples
were drawn and the clots Jysed spontaneously within Y2 hour even though
considerable fresh blood and fibrinogen were administered. Following the
demonstration of a lytic process,
EACA was given intravenously and
an almost immediate cessation of the
lysis occurred. The results of euglobulin lysis times performed on the
plasma samples obtained prior to and
after the administration of EACA
(table 2) show that GGBA was effective in inhibiting lysis, but to a lesser
· degree than was EACA.
GGBA is a naturally occurring
compound (Pisano, Abraham, and
Udenfriend, 1963) of low toxicity
(Kamiya, Kiyota, and Kita, 1962).
We have shown here that it, like
EACA, can inhibit the lysis of a clot
made from the plasma of a patient
with pathological fibrinolytic activity.
Therefore, it appears that GGBA, like
EACA, interferes with the activation
of human plasminogen by the naturally occurring activator. This work
also confirms that GGBA inhibits the
formation of clots when it is added to
normal plasma in the one-stage prothrombin or the partial thromboplastin time tests, while EACA has no
effect.
The mechanism of action of GGBA
in the formation and lysis of blood
clots is unknown.

TABLE 1

Effect EACA and GGBA on the One-Stage Prothrombin and Partial
Thromboplastin Times

No . of Samples

One-Stage
Prothrombin Time
Mean

I

Partial Thromboplastin Time

S.D.*

Mean

0.7
0.7
1.0

76
76
89

sec

Saline control .
EACA , 0.1 M . . .
GGBA , 0.1 M .

* S.D .

15
15
15

12.8
13 .2
16.0

I

I

S.D.*

sec

5
6
14

standard deviation.

Summary

The addition of y-guanidinobutyric
acid (GGBA) to human plasma significantly prolonged the one-stage prothrombin and the partial thromboplastin times. On the other hand, the
addition of e-aminocaproic acid
(EACA) had no significant effect on
either of these tests. GGBA inhibited
the lysis of a clot that was formed
from the euglobulin fraction of the
blood of an obstetrical patient with
active fibrinolysis. EACA inhibited the
lysis to a lesser degree.
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Electron Microscopic Observations of
Human Leucocytes
II. Appearance in Naturally Occurring Fevers*
F. GOODALE,t E. A. HILLMAN,t AND R. FILLMOREt

Departments of Pathology, Albany Medical College, Albany, New York, and
Medical College of Virginia, Richmond

Believing as I do in the
continuity of nature, I
cannot
stop
abruptly
where our microscopes
cease to be of use. Here
the vision of the mind
authoritatively
supplements the vision of the
eye.
John Tyndall
Address at Belfast, 1874

When human leucocytes are artificially stimulated in vivo or in vitro by
a bacterial pyrogen, they release, without destroying themselves, a pyrogenic
substance that differs chemically and
biologically from the original bacterial pyrogen (Snell et al., 1956; Cranston et al., 1956). Although leucocytic
pyrogen has not been seen, or at least
recognized, by light or phase microscope, a finely granular extracellular
material (fig. 1) is consistently visible
by electron microscope in artificially
stimulated leucocyte preparations that
we know to be pyrogenic (Goodale,
Fillmore, and Hillman, 1962).
We are reasonably certain that the
granular material is a genuine cellular product in response to the stimulation and, although definite proof is
lacking, that it represents, at least in
part, leucocytic pyrogen. If the artificially induced granular material does
indeed represent leucocytic pyrogen,
and if leucocytic pyrogen is responsible for naturally occurring human fevers, it would follow that the same
granular material should also be visible in leucocyte preparations from
febrile patients with a variety of diseases. The purpose of this study is to
report the findings by electron microscope in preparations of human leucocytes that have been "naturally" stim-

* Presented in part at the Fifth International Congress for Electron Microscopy, Philadelphia, August 29 to September 5, 1962. This work was supported
by Public Health Service Grant E-3720
from the National Institute of Allergy
and Infectious Diseases, by a grant-in-aid
from Eli Lily & Company, and by a grant
from the John A. Hartford Foundation.
t Dr. Goodale and Miss Hillman are
now at the Medical College of Virginia;
Dr. Fillmore is at St. Vincent's Hospital,
New York, N.Y.
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ulated in vivo by pathological processes
ranging from infections to terminal
carcinomas.
Materials and Methods

All equipment was sterilized and
made pyrogen-free by heating at 180°
for 2 hours. Glassware was siliconized.
A 3 % dextran solution (molecular
weight 186,000 in 0.9% saline, from
Pharmachemical Corporation, Bethlehem, Pa.), was usually used to sediment
the erythrocytes. This solution was
tested in rabbits to ensure its freedom
from pyrogens, as was the autoclaved
0.9% saline that was used for control
purposes. The patients (table 1) were
drawn from the medical and surgical
wards of the Albany Medical Center
Hospital, without selection as to age,
type of disease, or treatment but with
regard only to the height and duration
of the fever.
Blood (20 ml) was drawn from an
antecubital vein of each febrile patient
into a glass syringe with the use of
heparin (10,000 U.S.P. units per 10
ml) as the anticoagulant. When the patients had been afebrile for at least 48
hours (except for patient # 17 in table
1, who had been afebrile 20 hours) 20
ml of blood were again drawn and a
control leucocyte preparation made by
exactly the same method as that used
for the febrile leucocyte preparation.
Many patients died before becoming
afebrile, so that from them control
samples could not be obtained. The
blood was divided into two equal parts
and placed in centrifuge tubes. In
most cases a volume of 3 % dextran
equal to the volume of blood was
added to sediment the erythrocytes. (In
a few instances erythrocyte sedimentation was accomplished over a longer
period without the use of dextran.)
After sedimentation for 20 minutes in
a 37°C water bath, the leucocyte-rich
plasma from each sample was aspi-

rated and centrifuged at 4 °C for 5
minutes at 1,000 rpm (250 X g) in an
International Refrigerated Centrifuge,
model PR-2. Unless otherwise stated,
all subsequent steps were carried out
at 4°C.
The supernatant fluids were discarded and one of the two cell buttons thus obtained were processed as
follows. The cells were washed twice,
with 10 ml of 0.9 % saline for each
wash and then incubated in 10 ml of
saline for 30 minutes at 37°C. They
were then fixed and embedded exactly
as to be described for the cells in the
second button. The cells in the second
button were fixed immediately for 1
hour with 2 % osmium tetroxide in
Dalton's buffer (pH 7.4). The osmiumleucocyte mixture was centrifuged at
1,000 rpm for 5 minutes and the supernatant discarded. After suspension
and thorough mixing in 10% ethanol,
the cells were centrifuged at 1,000 rpm
for 3 minutes. In this manner the cells
were dehydrated through a series of
graded ethanol solutions, washed three
times in absolute ethanol, once in equal
parts of absolute ethanol and methacrylate (7 parts butyl methacrylate to 1
part methacrylate), and then washed
once in the methacrylate mixture
alone. Final embedding was in gelatin
capsules containing the prepolymerized
methacrylate mixture with 1.5% benzoyl peroxide as a catalyst. Polymerization was completed at 55°C overnight.
Sections for both phase and electron
microscopy were cut with a Servall
Porter-Blum microtome by using glass
knives. Sections were mounted on
formvar-coated grids and were examined with either a Siemens Elmiskop
I (60 KV), RCA EMU-3F (50 KV), or
RCA EMU-3G (50 KV) electron microscope. Most grids were examined
unstained but a few were stained with

uranyl acetate by floating them on a
1 % solution for 15 to 45 minutes at
room temperature, then washing (by
flotation) in distilled water for 1 to 2
minutes. A few additional grids were
stained with lead (Karnovsky, 1961).
For each patient in whom the granular
m aterial was easily found, a minimum
of eight and an average of ten "febrile" and a similar number of control
(if obtainable) grids were examined.
For each patient in whom the granular
material was not easily seen or not
seen at all, up to 50 grids were examined with an average of approximately
25. Selection of patients occurred only
in that we tried to find adult patients
with fevers ranging from mild to
marked and from a few hours to sometimes several weeks' duration.

Results
The results are summarized in tables 1 and 2. The finely granular extracellular material present in electron
micrographs of leucocyte preparations
from naturally febrile patients is morphologically identical to that seen in
artificially stimulated leucocyte preparations. The granules sometimes appear singly but usually are in clumps
or aggregates varying from about 0.1
to 1.0 p, in diameter. Individual granules are of two sizes: the smaller (approximately 50 A in diameter) make
up the great bulk of the aggregates
while the larger (400 to 800 A in diameter) relatively infrequent granules
are usually peripherally located. The
only morphological difference between
the two types of leucocyte preparations
is in the Jeucocytes themselves. Those
cells artificially stimulated appear normal (figs. 1 and 2), while those "naturally" stimulated by the febrile process (figs. 3 to 8), almost all contain
cytoplasmic vacuoles, from 0.2 to 2.0
p, in diameter, from 1 or 2 to 20 in

number, with many of them containing the finely granular material. The
number of vacuoles and the amount of
granular material in vacuoles were
greatest when the blood was drawn as
the fever was rising. About half the
vacuoles contain, in addition to the
granular material, rounded bodies, 800
to 1200 A in diameter, with distinct
external membranes. These bodies are
in the same size range as the larger
granules of the extracellular material,
but whereas the latter have a uniform
appearance throughout, those in the
vacuoles usually appear empty. In patients afebrile for 48 hours, normal
cell structure was observed (fig. 7).
In 14 cases, half of the leucocytes
were washed free of plasma and incubated with saline prior to preparation
for the electron microscope in order to
find out if they released granular material during incubation. Eight of these
preparations contained the granular
material either within cytoplasmic vacuoles or outside the cell.
Although the quantity of granular
material in the leucocyte preparations
cannot be accurately assessed, it is
possible to say (1) that all preparations
of leucocytes collected while the fever
was rising or stable (15 cases) contained the granular material, (2) that
leucocytes from patients with rising
fevers are frequently vacuolated and
that the vacuoles often contain granular material, and (3) that granular material is usually not seen in leucocyte
preparations collected while the fever
is waning (3 of 7 cases) and is infrequently (2 of 12 cases) seen when no
fever is present.
In Jeucocyte preparations from nine
patients, phagocytosis of platelets by
neutrophils was seen (fig. 8). The platelets were generally intact and could be
easily recognized. Platelet phagocytes.is
7

TABLE 1

Data from 22 Patients with Fevers Due to a Variety of Diseases

Electron Microscope Observations

Clinical Data
'

No. Age Sex Race

--

Disease

Temperature•
(°F) at bleeding

Treatmentb

Presence of granular material
PhagoCondition
cytosis
when afebrile Febrile specimen'
of
specimens
Afebrile platewere taken
specimens
Saline
lets
Fresh incubation

- - - -

1

25

F

w

Hodgkin's disease, labial 104, stable
abscess

2

27

F

N

Lobar pneumonia

3

29

M

w

100.2

1'

4

40

F

w

Von Recklinghausen 's
disease
Malignant melanoma

102

1

5

40

F

N

Cholangitis jaundice

102.7

1'

6

46

F

w

Fracture of humerus

103

1

7

47

F

w

Fracture of femur

101.5

1

8

46

M

w

Acute pyelonephritis

101 .3

1'

9

49

F

w

Hodgkin's disease

101

1'

10

50

M

w

101

1'

11

54

M

w

101.5

12

54

F

w

Thrombophlebitis with
popliteal abscess
Thrombotic thrombo purpura
cytopenic
with cerebral hemorrhage
Carcinoma of breast
with metastases

103

13

57

M

w

Carcinoma of tongue

14

60

M

w

15

61

M

w

16

62

F

w

Bilateral leg amputation
for gangrene
Postoperative pneumonia
Subacute bacterial endocarditis
Lymphosarcoma

I

105. 6, stable

Aspirin
D emerol
Penicillin
Penicillin
Codeine
Aspirin
Codeine
Penicillin
Streptomycin
Neomycin

Improved

I.C.
E .C.

Not done None

No

Improved

LC.

Not done None

No

Improved

I.C.

Not done None

No

Deadd

I.C.

None

Not done

Yes

Deadd

Yes

Aspirin
Nem butal
Codeine
Penicillin
Streptomycin
Chloromycetin
Cortisone
Chloromycetin
Aspirin
Phenobarbital
Penicillin

Improved

I.C. Not done Not done
E .C.
None None
None

Improved

None I.C.

None

Yes

Improved

I.C.

LC.

None

Yes

Improved

I.C .
E.C.

I.C.
E.C.

None

Yes

Improved

Yes

1

Cortisone
Chloromycetin
Aspirin

Deadd

I.C.
Not done I.C.
E.C .
E.C.
None None
Not done

1

Penicillin
Aspirin
Chloromycetin
Streptomycin
Penicillin
Codeine
Leucovorin
None

D eadd

E.C.

None

Not done

No

Deadd

I.C.
E.C.

Not done Not done

No

D eadd

None Not done Not done

No

Improved

None None

None

No

Deadd

I.C.

Not done

No

104, stable

102

1

100.5

1

100 . 5, stable

Penicillin
Aspirin
Aspirin
Thorazine
Codeine

l.C.

No

No

Direction of arrow indicates whether the temperature was rising or falling at the time the blood was drawn; temperatures
are oral unless otherwise indicated and taken within 15 m inutes of the blood sample.
b Treatment listed is that which the patient was receiving when the blood was drawn and for at least the previous 24 hours.
' I.C. = intracellular ; E .C . = extracellular.
d Patient was febrile until death.
0
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TABLE !-Continued

Data from 22 Patients with Fevers Due to a Variety of Diseases
Electron Microscope Observations

Clinical Data

Presence of granular material
PhagoCondition
cytosis
when afebrile Febrile specimen'
of
specimens
Afebrile platewere taken
specimens
lets
Saline
Fresh incubation

I
No. Age Sex Race

--

--

-

Disease

Temperature"
(°F ) at bleeding

Treatment'

- --

r

17
18

67
68

F
F

w
w

19

70

F

w

20

71

M

w

21

72

F

N

Congestive heart failure
Pneumonia
Acute pyelonephritis

22

74

M

w

Urinary tract infection

Fever of unknown origin
102
Carcinoma of breast 103 .4, stable
with metastases
(rectal)
Mycosis fungoides
100

r
100 .2 r
101
r
100 r

Cytomel
Prednisone

Improved
Deadd

I.C.
I.C.
None I.C.

Gantrisin
Cytoxan
None

Improved

I.C .

Not done None

No

Deadd

E .C.

Not done

Yes

None

Deadd

Not done

No

Achromycin

Improved

I.C .
E.C.
I.C .

l.C.
E.C.
None
I.C .

None

Yes

E.C .'
Not done

Yes
No

' Patient was afebrile less than 24 hours.

Fig. I- Portion of neutrophil , artificially stimulated in vitro by incubation for 1 hour with bacterial endotoxin (Lipexal) . To the left of
the cell are aggregates of granular material which may represent, in part at least, leucocytic pyrogen. It is morphologically indistinguishable
from the granular material seen in leucocyte preparations "naturally" stimulated in vivo by a variety of disease processes (figs . 3 to 7) . Un-.
stained, X 27,840.
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TABLE 2

Summary of Electron Microscopic
Findings in Leucocyte Preparations
from 22 Febrile Patients.
Blood samples for controls could
be obtained from only 12 patients
because the remaining 10 patients
died before becoming afebrile .

Temperature of Patient

Rising or at peak ..
Falling . . . . . . . .
Afebrile controls . . . . . .

Presence of
Granular
Material
Yes

No

15*
3*
2

0
4
10

* In one of these cases granular
material was not seen in the fresh~
specimen but was present within
leucocytes in the saline-incubated
specimen .

Fig. 2-To the left and below the visible
portion of the lymphocyte, and between
parts of two erythrocytes, is an aggregate
of granular material about 1.0 µ, in diameter. In this ease 10 ml of whole
blood from one of the authors was incubated for 1 hour in vitro with 0.5 µ, of
bacterial endotoxin (Lipexal) and then
returned intravenously to the donor.
Twenty-five minutes later chills and rising fever began, at which time blood for
this preparation was drawn. The granular material here is made up of fine
particles averaging approximately 50 A
diameter. Stained with uranyl acetate, X
48,000.

10

Fig. 3 (Above)-Eosinophil from patient
9, table 1. Blood was drawn when temperature was 101°F and rising. Irregularly
shaped aggregates of granular material
appear to the right above the cell. Individual particles comprising these aggregates are relatively coarse, averaging approximately 400 A. Stained with uranyl
acetate, X 60,800.
Fig. 4 (Left)- Portion of monocyte from
patient 1, table 1, showing the granular
material within a cytoplasmic vacuole.
The sample was drawn as the temperature
was stable at 104°F. Unstained, X 56,000.

11

Fig. 5 (Left, above)- Neutrophil from
patient 8, table 1, showing several large,
almost empty vacuoles. Two contain small
amounts of granular material and a number of minute, apparently empty vesicles.
As this sample was taken the patient was
having chills and his temperature was
101.3°F and rising. Unstained, x 18,000.

Fig. 7 (above)-From the same patient as
figures 5 and 6. Blood drawn when he had
been afebrile for 48 hours. This monocyte
shows typical decrease in size and number of vacuoles in early post febrile
period. Unstained, X 32,400.

Fig. 6 (Left, below)- From the same patient as figure 5. Adjacent to the nucleus
is a vacuole containing both granular material and a few tiny vesicles. Stained
with lead, X 50,000.
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was apparently not related to the waxing or waning of a patient's fever.
However, in every instance in which
phagocytosis of platelets was observed,
granular material was also seen. No
phagocytosis of erythrocytes was seen.
Discussion

If the granular material does, in
fact, represent leucocytic pyrogen, why
is it not seen in all febrile patients and
why is it occasionally seen when patients are afebrile? In the present study
it was observed in all 15 patients whose
temperature was rising or stable at an
elevated level when the blood sample
was drawn. However, when blood was
drawn as the patient's fever was falling toward normal, the granular material was seen in only three of seven
cases, suggesting that its production
may cease or be curtailed as the feverproducing stimulus weakens. Actually,
in light of previous evidence that leucocytic pyrogen, whether artificially
(Goodale and Gander 1962a and
1962b) or naturally induced (Snell,
1961 , 1962), is effective in the circulating blood in extremely low concentration, one might anticipate difficulty
seeing it in occasional cases.
As part of a previous study (Goodale
et al., 1962) we examined leucocyte
preparations from 30 healthy afebrile
volunteers and saw the granular material in two of them. In these two

Fig. 8-Portion of monocyte from patient 17, table 1. Blood drawn when
temperature was 102°F and rising. The
phagocytized platelet shows few, if any,
signs of disintegration. Although no granular material is visible in this illustration,
it was seen in all leucocyte preparations
in which phagocytosis of platelets occurred. Unstained, X 60,000.
14

cases we felt that the granular material might have been due to contamination of the leucocyte preparation by
bacterial endotoxin prior to incubation.
In the present study there were two
patients whose leucocyte preparations
contained the granular material, not
only when they were febrile but also
when they were afebrile. One of the
patients C* 17, table 1) had been afebrile Jess than 24 hours and became
febrile again the day after her control
sample was drawn. The other patient
C* 10), although his temperature was
normal, had a large, open, and infected
wound on one leg. Perhaps a threshold
exists beneath which there is insufficient
circulating pyrogen to elicit a measurable febrile response, but still enough
to be sometimes visible by electron
microscopy.
The only difference we have noted
between leucocyte preparations which
have been artificially stimulated in
vitro to release their pyrogen, and those
"naturalJy" stimulated, is that in the
latter the granular material often appears in the cell cytoplasm within
vacuoles. Whether it is being formed
inside the celJ or whether it has been
produced at the cell surface and then
phagocytized, we do not know. Conditions are undoubtedly more favorable
for phagocytosis in vivo than in vitro.
We are not able at present to assess
accurately the amount of granular material present in a leucocyte preparation. Therefore, we can make no statements as to whether height or duration
of fever, type of disease, or method of
treatment had any detectable effect on
the amount or location of granular material. Cortisone has been reported
(Atkins et al, 1955) to have antipyretic
properties. Three of the patients (*8,
11, and 18, table 1) in the present study
were receiving either cortisone or

*

prednisone. In patients
8 and 18,
whose temperatures were rising or at
peak, leucocytic pyrogen was observed.
In patient *11, whose temperature
was falling, leucocytic pyrogen was not
seen. From these few observations we
can say only that if the granular material is or contains Jeucocytic pyrogen,
then cortisone does not apparently exert its antipyretic effect by preventing
the formation or release of the pyrogen. However, the quantification of the
granular material must await more precise biological or chemical methods
than are now available.
When phagocytosis of platelets by
leucocytes occurred, it always occurred
in the presence of granular material.
Sometimes platelets in advanced stages
of disintegration within cytoplasmic
vacuoles resembled the granular material. We have observed platelet
phagocytosis in only one artificially
stimulated leucocyte preparation. Its
meaning in the present study is uncertain.
Summary

A granular material was visible by
electron microscopy in leucocyte preparations from 17 of 22 febrile patients
with a variety of diseases. It was seen
in all 15 patients whose temperature
was rising when the blood sample was
drawn, in 3 of 7 patients whose temperature was falling, and in 2 of 12
afebrile patients.
The granular material is morphologically identical to that seen in leucocyte preparations artificially stimulated
in vitro by bacterial endotoxins and
known to contain leucocytic pyrogen.
The present study would tend to
strengthen the association between the
granular material and Jeucocytic pyrogen, but the exact relationship has yet
to be proved.
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Oxygen Affinities
and Electrophoretic
Patterns of Hemoglobins
in

Trout and Basses
from Virginia*

JACK D. BURKE

Department of Anatomy
Medical College of Virginia, Richmond

Multiple hemoglobins in several different species of fishes were described
by using electrophoresis in 1959 by
Buhler and Shanks in the United States
Chandrasekhar in India, and Hashi:
moto and Matsuura in Japan. Consequently, using gene frequency data,
variant hemoglobins have been studied
in relation to such parameters as proportional changes of hemoglobins with
growth in salmon (Hashimoto and
Matsuura, 1960), and intraspecific
variation in cod and whiting by Sick
(1961). This paper is concerned with
hemoglobin polymorphism as it is related to interspecific variation in Micropterus dolomieui, the smallmouth
bass, and Micropterus salmoides, the
largemouth bass, as well as Salmo
gairdneri, the rainbow trout, and Salmo
trutta, the brown trout. Since the brook
trout, Salvelinus fontinalis, was available, it was also possible to compare
the trout hemoglobins generically.
A striking example of distribution
of fishes in freshwater is that of trout
and catfishes. Trout are ordinarily
found in cool, well aerated water having a high oxygen content, but catfishes can be found in shallow, warm
water with a low oxygen concentration. A comparison of the results by
Irving et al. (1941) on trout, with results reported by Haws and Goodnight
(1962) for catfishes, shows that hemoglobin affinity for oxygen is greater in
catfishes than in trout, when the measurements were made with similar
temperatures and carbon dioxide tensions. With other conditions being
favorable for reproduction and sustenance, it seems that the affinity of
hemoglobin for oxygen is a limiting
factor in the distribution of trout and
catfishes. This may be a general ecophysiological relationship-even operating at the interspecific level-since
it appears to be a factor in the distribution of fishes such as smallmouth
and largemouth basses, as well as in
trout. In this study is has been found
that the affinity of hemoglobin for oxygen is different in basses and trout, and
electropherograms on cellulose acetate
membranes show hemoglobin polymorphism in the basses as well as the
trout.

* Supported by U. S. Public Health
Research Grants H-365(and H-8774.
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Materials and Methods
The smallmouth bass were caught on
artificial bait in or near the rapids at
the Fall Line of the James River at
Richmond, Virginia (mean oxygen
content: greater than 7 mg per L). The
largemouth bass were taken on both
artificial bait and live minnows from
different ponds and lakes in east-central counties of Virginia (mean oxygen
content: less than 5 mg per L). All fishes
were collected in the spring, summer,
and fall months of the year. The fishes
were weighed on a simple field balance described by Burke (1963), and
the oxygen content of the water where
the fishes were caught was determined
by a modification of the Winkler
method with a 10-ml syringe (Burke,
1962a). All of the trout were obtained
from the State Trout Hatchery at
Marion, Virginia.
Blood was removed from the fishes
in the field, or in the laboratory if the
transportation distances were short.
The procedure of securing blood as described by Burke (1962b) was employed. Essentially, the technique used
here is that the posterior part of the
operculum was removed, a slit made
through the posterior branchial chamber and the pericardium, the heart
clipped, and the blood collected in a
heparinized pipette as it "welled" into
the pericardia! cavity.
Hemoglobin solutions for oxygen
affinity studies were prepared as follows. The blood was centrifuged, the
plasma decanted with a vacuum pipette, and the cells washed three times
in 0.11 M NaCl solution with intermittent centrifugation. The cells then
were hemolyzed by suspending them
in an equal volume of distilled water
overnight in a refrigerator. After gentle agitation on a rotator, the suspension was filtered, centrifuged at high
speed, and filtered again. The hemoglobin was made up in phosphate
buffers with an ionic strength of 0.3
and a pH of either 7.4 or 6.8; all
spectrophotometric readings at 640 m,u
were made at 25 ± 1 °C. Oxyhemoglobin affinity curves were determined
by the spectrophotometric method of
Burke and Powell (1962). After equilibration with air, percentages of
oxyhemoglobin were determined for
various oxygen tensions obtained manometrically using a tonometer, and
the following equation: y I 100 = A, -

A ,/ A, - A , where y is percentage oxyhemoglobin, A is absorbance, and r, s,
and o represent "reduced" hemoglobin,
partially oxygenated hemoglobin, and
fully oxygenated hemoglobin, respectively. This procedure was modified
from the methods described by Hall
(1935), Riggs (1951), Redmond (1955),
Rossi-Fanelli and Antonini (1958), and
personal communication with Dr.
Clyde Manwell of the University of
Illinois, Urbana. At least three oxyhemoglobin affinity curves were determined, both at pH 7.4 and 6.8 on
pooled blood samples, from two to four
fish of each species that were sexually
mature. Therefore, the points for each
curve shown in figs. 3 to 7 represent
mean values.
Before dilution, the hemoglobin solutions prepared for the determination
of the oxyhemoglobin affinity curves
were also used in spotting for electropherograms. Electrophoresis was carried out in a Gelman electrocab containing a barbital buffer with a pH
of 8.6, and an ionic strength of 0.05 µ,
at 250 V for 1 hour at room temperature. At least three electrophoretic
patterns were run on each hemoglobin
sample. The patterns were developed
on cellulose acetate membranes by
staining with bromphenol blue or
amido Black lOB, clearing in dilute
acetic acid solution, and drying in air.

SAL MO
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Using paper electrophoresis, Buhler
and Shanks (1959) reported three hemoglobin bands each for rainbow and
brook trout, and two bands for largemouth bass. With similar experimental
conditions, I was able to confirm their
results, but when cellulose acetate
membranes were used the hemoglobin
patterns were found to resolve more
clearly. The hemoglobins in rainbow
trout resolved into six bands, four
bands in brown trout and three bands
in brook trout, as shown in fig. 1. Using
free moving boundary electrophoresis,
Buhler (1963) reports three distinct
hemoglobins for rainbow trout. But
Tsuyuki and Gadd (1963) report 16
hemoglobins in rainbow and 15 in
brook trout with starch gel electrophoresis. In fig. 2 it is shown that three
hemoglobins were found in the smallmouth bass, and four bands characterize the hemoglobins in the largemouth
bass.
As shown in figs. 3, 4, and 5, re-
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Fig. 1-Electrophoretic patterns of hemoglobins formed
on cellulose acetate membranes are shown for trout: rainbow (Salmo gairdneri), brook (Salvelinus fontinalis), and
brown (Sa/mo trutta). Distance (in millimeters) of migration is shown as well as percentage of relative measure
(RF) . Except for the origin line, the bands are drawn in
relative density to each other.
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relative density to each other.
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Fig. 3-0xybemoglobin affinity curves for rainbow trout (Salmo gairdneri) determined
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Fig. 4-0xyhemoglobin affinity curves for brook trout (Salvelinus fontinalis) determined at 25°C.
spectively, the oxyhemoglobin affinity
curves in rainbow, brook, and brown
trout are different. At pH values of 7.4
and 6.8, rainbow trout hemoglobin was
50% saturated at 29 and 53 mm of Hg,
whereas in brook trout hemoglobin the
T,1• " ' = 34 and 56, and it was 31
and 45 mm of Hg in brown trout hemoglobin. At the same pH values where
Hb = HbO, , the oxygen tension was
14 and 93 mm of Hg in the smallmouth
bass, but 9 and 30 in the largemouth
bass as indicated in figs. 6 and 7.
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Discussio n

Studies by Krogh and Leitch (1919)
showed that blood of different fishes
was peculiarly sensitive in combining
with oxygen in the presence of different concentrations of carbon dioxide.
Earlier, Bohr et al. (1904) found that
the affinity of hemoglobin for oxygen
decreases with an increase in carbon
dioxide tension, and Christiansen et al.
(19 14) reported the reciprocal effect.
The term "Bohr effect" is now used to
include both of these conditions. In the

SALMO

TRUTTA

e , 6, 8

pH

100

z
0

80

f-

<t

a::

:>
f-

<t

60

(/)

f-

z

w

40

(,)

a::
w
Q.

20

0

10

20

30

40

50

OXYGEN

60

70

eo

90

TENSION

Fig. 5-0xyhemoglobin affinity curves for brown trout (Sa/mo trutta) determined at
25°C.
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Fig. 6-0xyhemoglobin affinity curves for smallmouth bass (Micropterus dolomieui)
determined at 25 °C.
work by Irving et al. (1941), the Bohr
effect was established for various fishes.
A comparison of the Bohr effect for
the trout results shown in figs. 3, 4 ,
and 5 may be shown by the ratio where
R = ~ logp'°/ ~ pH. For rainbow,
brook, and brown trout, "R" was calculated to be (-0.44), (-0.36), and
(-0.27), respectively. Not only does
the rainbow trout have a greater Bohr
effect, but its hemoglobin also has a
greater affinity for oxygen as indicated
previously. These two characteristics

may allow the rainbow trout to sustain
a greater activity than the brown (or
brook) trout, because more oxygen can
be unloaded to the tissues as blood
pH decreases, and allow it to tolerate
warmer water containing less oxygen
(Fry, 1957). lnterspecific hemoglobin
differences between rainbow and
brown trout are shown in fig. 1 when
the electrophoretic patterns are compared; the generic differences between
Salmo and Salvelinus are also shown.
As shown in fig. 2, interspecific dif19
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Fig. 7-0xyhemoglobin affinity curves for largemouth bass (Micropterus salmoides)
determined at 25°C.

ferences also occur in the hemoglobin
patterns of smallmouth and largemouth
basses. These differences may be related to the two ecophysiological factors differentiating the trout. First, the
hemoglobin of the largemouth bass has
a greater affinity for oxygen than does
that of the smallmouth bass, as shown
above. Assuming this difference to be
genetic, it would explain the ability of
the largemouth bass to inhabit waters
with a lower oxygen content, lower
turnover rate, and higher temperature.
Conversely, since the hemoglobin of
the smallmouth bass has a lower affinity for oxygen, this species would tend
to be restricted to those waters where
the temperature is lower and the oxygen content higher. Such conditions
are associated with mountain lakes and
streams, or fast flowing streams with
rapids.
The second factor is the Bohr effect;
this is, as the acidity increases, the
affinity of hemoglobin for oxygen decreases. The Bohr effect difference between the two species is seen when
the curves in fig. 6 (R = -1. 3 7) are
compared with those in fig. 7 (R =
-0.73). The decreasing oxyhemoglobin affinity in the smallmouth bass is
20

noticeably associated with an increasing Bohr effect. This relation is advantageous when metabolic demands
require a high oxygen unloading tension in tissues (Foreman, 1954). It may
also explain why it is that, as the acid
metabolites form in cellular respiration
(Prosser and Brown, 1961), the hemoglobin is buffered at a lower pH and
more oxygen is unloaded to the cells.
Thus, the smallmouth bass takes on
.a characteristic fighting habit when
hooked, where an increasing supply of
oxygen would be necessary to sustain
greater activity. This unusual activity
is indicated in a statement by Henshall (Harlan and Speaker, 1951) as
follows: "He has the arrowy rush and
vigor of a trout, the untiring strength
and bold leap of a salmon . . . the
gamest fish that swims."
Therefore, interspecific hemoglobin
differences-as shown by certain parameters such as electrophoretic patterns, oxyhemoglobin affinities, and
Bohr effects-are important in establishing the limits, sometimes overlapping, of the habitats which may be
occupied by smallmouth and largemouth basses, as well as trout.

Summary
1. Hemoglobin solutions were prepared from pooled samples of blood
taken from each of the following species; Sa/mo gairdneri, the rainbow
trout; Salvelinus fontinalis, the brook
trout; Salmo trutta, the brown trout;
Micropterus dolomieui, the smallmouth bass; Micropterus salmoides,
the largemouth bass.
2. Hemoglobin electrophoretic patterns for each species were developed
on cellulose acetate membranes.
3. Oxyhemoglobin affinity curves
were determined spectrophotometrically on different hemoglobin solutions
from each species.
4. Interspecific differences
concerned with hemoglobin electrophoretic patterns, oxyhemoglobin affinities,
and the Bohr effect were shown for
both trout and basses.
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"Some of my friends have even
asserted that a Ph.D. thesis should
be the greatest scientific work a
man has ever done and perhaps
ever will do, and should wait until
he is thoroughly able to state his
life work. I do not go along with
this. I mean merely that if the
thesis is not in fact such an overwhelming task, it should at least
be in intention the gateway to
vigorous creative work. Lord only
knows that there are enough problems yet to be solved, books to
be written, and music to be composed! Yet for all but a very few,
the path to these lies through the
performance of perfunctory tasks
which in nine cases out of ten
have no compelling reason to be
performed. Heaven save us from
the first novels which are written
because a young man desires the
prestige of being a novelist rather
than because he has something to
say! Heaven save us likewise from
the mathematical papers which are
correct and elegant but without
body or spirit. Heaven save us
above all from the snobbery which
not only admits the possibility of
this thin and perfunctory work,
but which cries out in a spirit of
shrinking arrogance against the
competition of vigor and ideas,
wherever these may be found!"
Norbert Weiner, The Human Use of Human Beings:
Cybernetics and Society .
Garden City, New York:
Doubleday and Company,
Inc., 1954, p. 133 .
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On the Mathematical
Basis of
Medical Diagnosis*
MALCOLM E. TURNER

Department of Biometry
Emory University School of Medicine
Atlanta, Georgia
It used to be that a good physician
could assimilate, retain, and recall
most of the known facts about medicine. Beginning with the years prior
to World War II, it became evident
this was no longer possible. The systemizations to condense facts in other
fields had not progressed as far as had
the accumulation of facts in medicine.
Thus, we have seen the emergence of
the "medical specialist" and the "team
approach" to disease. Even this multiple physician approach is beginning
to fail before the exponentially increasing array of information about
pathological processes.
I believe that there are just three
things that can be done about this
overwhelming wealth of information:
(1) We can develop more specialists
that are even more specialized, but already this approach is being hampered
by problems of communication. (2)
We can develop more encompassing
theories of disease so as to reduce the
large number of facts to a relatively
few simple hypotheses. This is the
goal of the model builders, perhaps
the ideal approach, but we cannot afford to wait for this nirvana. And
even if this were possible now we
would only reach a temporary plateau
upon which new mountains of data
would pile. (3) The third approach is
to utilize such mechanical and electronic slaves as are available to help
us organize, retain, recall, and communicate those observations on disease worthy of record. I believe we

* Based on a lecture presented at
Grand Rounds, Department of Medicine,
Kansas University Medical Center, December 9, 1964, and supported in part by
the Kaw Valley Heart Association.
22

are forced to develop this third approach while evolving the best compromise for the first approach and
pursuing the second with all possible
vigor.
In order to utilize the latest engineering achievements we must be very
clear about what instructions we give.
If we are not, we may find ourselves
in the position of the "sorcerer's apprentice" who failed to learn how to
turn off the water; only here we will
have stacks and stacks of meaningless
paper.
It is sensible to examine first how
the human computer works when
making medical diagnoses (or any
kind of inductive or scientific inference) by discussing hypotheses which
have attempted to describe this process. The machinery should be taught
how to imitate the human diagnostician. Perhaps then we can find ways
to improve processes when coupling
the machine and human brain.
The concepts to be presented here
have been discussed before in connection with medical diagnosis by a number of authors. I draw attention particularly to the papers by Neyman
(1947, 1950), Yerushalmy (1947),
Chiang (1951), Chiang, Hodges, and
Yerushalmy (1955), Paycha (1958),
Arnois, Silverman, and Turner (1959),
Ledley and Lusted (1959, 1960),
Shephard and Turner (1959), Tanimoto (1960), Cady et al. (1961), Van
Woerkom and Brodman (1961), Ward
and Hook (1962), Entwisle and Entwisle (1963), Collen et al. (1964),
and Nissen-Meyer (1964).
The discussion is divided into two
sections. The first section deals with
the problem of construction of a
scheme of classification of disease entities. This may be termed the problem
of classification. The second section
deals with the credibility of a diagnosis after a patient has been assigned
to a disease entity. The degree of credence attached to possible assignments
may be used as the basis of assignment, and hence the basis of medical
diagnosis itself. I will term this the
problem of credence.
The Problem of Classification
It is convenient to refer to the
state of a patient at a particular instant of time. Let us suppose that at
some such instant a patient (or normal individual) may be completely

characterized by the concomitant values of a sufficiently large number of
variables. Some of these variables,
such as sex, are constant throughout
life; some, such as height and weight,
change relatively slowly. Others, such
as blood cholesterol, vary dramatically
at different times. Some are nearly
constant because of feedback control
mechanisms. Some are periodic. Some
strikingly reflect impacts from the environment. Some are random. Many
are interrelated in complex fashions,
and their nature is sought by the
model builders. Whatever are the
characteristics of the various variables,
however, the set of values applying to
a sufficiently large collection of variables uniquely characterizes the state
of the individual at the particular
point in time. It may be helpful to
think in geometric terms. Suppose
each variable is the axis of a geometrical space. If there are n variables
there will be n axes for our space, and
we will have an n-dimensional space.
(It will not harm our concept to visualize a two-dimensional space with,
for example, the first axis, X1 , equal
to the weight of the individual, and
the second axis, X2 , equal to the systolic blood pressure of the individual.)
Now, at a particular instant of time,
the set of values for the n variables
will determine a single point in the
state space. This single point will be
called the state point of the individual
at the particular instant. It is easy to
visualize that in an instant the point
can shift slightly from its original
position. So, through life, from the
moment of birth (or earlier) to the
moment of death, the individual will
be uniquely described by a succession
of adjacent state points. Imagining
these points strung together we have
a line of state points twisting and
bending through the state space from
birth to death. This is indeed an abstract view of a patient, as a line in
state space, a life line. One may immediately object to this "coldy mechanized" view. However, there is no
reason in principle why some of the
n variables cannot represent the emotional and affective states of the individual at each instant. Theoretically,
every human experience and feeling
can be represented as values on the
axes, or on combinations of the axes,
in the state space.
Suppose there is a line in state space
for every person in the world, a

bundle of more than three billion lines!
As the course of life is somewhat similar for all of us, the life lines will
have parallel tendencies although no
two lines will be identical (possible but
improbable). Typical individuals will
lie toward the center of the bundle,
atypical ones toward the outside.
Clearly, life lines will not exist in all
parts of the state space. The dictates
of life are such that the living mechanism will not function in all possible
states. Thus, very extreme life lines
will not exist. Possible but still extreme life lines will occur rarely,
whereas mild, atypical lines will occur
much more frequently in this conception. (This central tendency of the life
lines is predicted by the "central limit
theorems" of mathematical probability, and is confirmed by common experience; the mathematical function
most used to describe the density of
lines at various distances from the
center of the bundle is termed the normal or Gaussian distribution.)
Some of the lines may represent
lives which at times have more than
negligible malfunction. Then the individual is diseased. Satellite bundles of
diseased life lines occur with new
centers of density. If it is clear (sufficiently low density of lines between
regions of high density) that these satellite clusters are not fortuitous irregularities in the tail of the normal density,
then the satellites themselves are recognized as distinct disease entities and
are appropriately named. Sometimes
partial tails of the normal density
function are taken to be disease entities (although not distinct) when the
respective states represent some degree
of malfunction or pathology. It is useful to distinguish these two patterns of
disease.
In the past, recognition of disease
pattern has been largely heuristic.
Now, powerful quantitative tools exist
for aiding this process. Of particular
interest is the generalized measure of
distance (squared) between cluster
centers, due to Mahalanobis (1930,
1936) and known as Mahalanobis'
D 2 • The central idea in the use of D 2
is the measure of the distance (squared)
between cluster centers, taking into
account the functional dependencies
between state variables. If the distance
between centers is large, compared to
the scatter about the centers, then
distinct disease entities are recognized.
Statistical tests of significance help to
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distinguish real from accidental clustering. The method of "discriminant
functions," due to Fisher (1938), and
the "generalized T' test," due to Hotelling (1931), are mathematically equivalent procedures to D 2 • These and some
other procedures with similar objectives are frequently referred to as
"cluster analysis." An over-all view
of the rationale, mathematical derivation, and uses of these procedures is
found in Rao (1952). The elementary
discussions in Shephard and Turner
(1959) and Hanna, Turner, and
Hughes (1963) may be helpful.
Measurements of distances between
cluster centers may be made for various fixed ages yielding a "distance
function" of age. Alternatively, adjustments of the states for age may be
made by replacing observed states
with corresponding (sliding up or down
the average life line) states at some
age. The principles of "covariance
analysis" are appropriate here.
There is one final consideration
about choice of procedures for cluster
analysis before we pass on to the problem of credence. The D 2-T' discriminant function procedure is based upon
one rather restrictive assumption about
the equality of scatter, and interdependencies between variables, about
two centers which we wish to measure
the distance between. This assumption
often is not even approximately true
when comparing normal and diseased
life line bundles. In this case, generalized procedures are available (Kendall,
1957), although they have not been
used widely.
The Problem of Credence

Suppose we have divided the state
space into a set of not necessarily
mutually exclusive regions recognized
as disease entities plus the "normal"
region. It is immaterial whether informal or formal procedures were used
in arriving at the regions. We will take
the regions to be fixed for purposes
of application of the ideas of this
section. Let us realize, however, that
these regions will be rearranged at
times as information about the state
space accumulates. Further suppose
that a physician has observations corresponding to the values of some of
the state variables. At this point he arrives at a provisional diagnosis (i.e.,
he assigns the "patient" to one of the
regions in state space). But this diagnosis suffers from uncertainty due to
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at least two causes: (1) his information
is incomplete as he cannot measure
all state variables, and (2) those measurements he has (signs, symptoms,
tests, etc.) contain intrinsic errors of
a random or systematic nature, due
either to physiological variation or to
measurement error. The physician now
decides whether to take more measurements (new measurements or replications of old ones), to begin treatment
based on his provisional diagnosis, or
both. His behavior in these two important respects is predicated largely
upon his belief in his own diagnosis.
Thus there is the problem of how best
to measure and reason about the subjective phenomenon, credibility.
We will relate credibility to probability by first examining some concepts
of probability. The notion of mathematical probability first arose in the
Italian Renaissance as a theory of repetitive happenings which was applied
to games of chance and even to life
insurance. The philosophical and
mathematical bases of the theory of
probability were subject to much dispute until the purely mathematical aspe.cts of the theory were abstracted
(cf. Kolmogorov, 1956). In this modern guise the essential ideas of the
theory of probability can be simply
stated. We consider the set of possible
results of an experiment. Call these
results Ai, A., · · ·, Ak. Suppose B
is another kind of result of the same
experiment. We will let A ,B stand
for the event, "both A , and B happen."
We will let Ai U B stand for the event,
"either A, or B, or both A, and B
happen." We will let S stand for the
event which must happen, and 0 stand
for the event which cannot happen.
Then if we write A,A. = 0 we imply
that both Ai and A. cannot both happen. Or if we write Ai U B = S we
imply that either A, or B must happen.
Now the theory of probability concerns
certain real numbers which are assigned to each possible experimental
result and are called "probabilities."
Thus; we wi\l write p(A,) and read,
"the probability that Ai happens," or
write p(A ,
B) and read "the probability that either A, or B happens," and
so forth. It is important to realize that
the theory of probability itself does
rtot provide prescriptions for assigning the probabilities. These prescriptions must be obtained from other
considerations. However, the probabilities must satisfy three restrictions

(called the axioms of probability): (1)
p(A ,) ~ 0 where A , is any result, (2)
p(S)
1, and (3) if AiA2
0 then
p(A, U A .) = p(A ,)
p(A2). This is

=

+

=

all we need to establish from the theorems of the theory of probability. For
example, we can derive that p(O) = 0,
that 0 ;:;:; p(A ,) ;:;:; 1, that p(A , U B) =
p(A ,) + p(B) - p(A ,B), and many
more. Before proceeding we will need
to make one further definition. Let
p(BI A,) = p(A iB)I p(A,) and read p(B I
Ai) as "the probability that B will happen given that A i has already happened," or "the probability of B given
A , ," for short. Then we say that A ,
and B are independent if p(B A,) =
p(B). If B and A, are independent then
we see that p(A ,B) = p(A,)p(B), the
famous rule of multiplication for independent events.
It would be easy to demonstrate
the truth of a very remarkable formula discovered by Thomas Bayes
(1763) and now known as Bayes'
Theorem. This formula can be written:

I

I A,) / p(B).
where p(B) = p(A,)p(B I A ,) + p(A2)
p(B I A ,) + · · · p(Ak)p(B I A k), and
p(A ,

I B)

p(A,)p(B

supposing that A,, A,, · · ·, Ak are
mutually exclusive events.
Probabilities have to do with the
frequency of occurrence of possible
outcomes of an experiment. Let us put
aside all thoughts about probabilities
and think about a set of possible hypotheses, H i , H. , · · ·, H • , to explain
some observed phenomenon. Suppose
we would like to measure the credence
we place in each hypothesis. What
restrictions should we impose upon
our measure? It has been suggested
(cf. Polya, 1954) that rational humans
behave as though their credences (write
C(Hi), C(H2), etc., for real measures)
obeyed the following three restrictions:
(1) C(H,) ~ 0 where H , is any hypothesis, (2) C(S) = 1 where S = H, U
H, U · · · U H., and (3) if H,H 2 = 0
then C(H, U H2) = C(H,) + C(H2). Restriction (1) says that the measure of
credibility which we will use is never
negative. Restriction (2) says that the
credence in at least one hypothesis is
assigned the numerical quantity one.
Finally, restriction (3) says that if two
hypotheses cannot both be right then
the degree of credence to be placed
upon the compound hypothesis "either
H, or H 2" is simply the sum of the
respective individual credences.

The theory of credibility is identical
in mathematical content to the theory
of probability, although the purposes
of the two theories are quite different.
But since they are mathematically
equivalent, any theorem of probability
can be taken over for credence theory,
and in fact, there is no logical reason
why we cannot mix probabilities and
credences in any valid formula derived from the axioms of probability.
For example, the following mixed
version of Bayes' Theorem is perfectly
valid:
C (H,

IB )

= C (H, )p (B I H i)/p (B ).

This formula may be interpreted to
say that if one wants to calculate the
credence to be placed in hypothesis
number 1, given the observations B ,
then we need to know two things: (1)
the credence placed in hypothesis number 1 before B was observed, and (2)
the probability that B would be observed if hypothesis number 1 were
true. Having similar information for
all alternative hypotheses will allow
computation of the denominator. This
is a remarkable result because it provides a complete solution to the problem of assigning credences to various
hypotheses or diagnoses in light of
any given observations.
The key to using the mixed version
of Bayes' Theorem for measuring or
comparing credence in alternative diagnoses is in the source of the prior
credences, C(H,), C(H2), etc. We consider four different situations.
1. Prior credences estimated as relative frequencies of disease entity in a
particular population. Sometimes it is
possible to estimate how often each
disease entity occurs in a population
from which a current patient was
drawn at random. Such relative frequencies then may be used as proper
measures of the prior credence.
2. Prior credences locally uniform.
The posterior credence, C(H, [ B) will
not be much affected by C(H,), the
prior credence, if there is sufficient
information in the observations B . This
situation can be ensured by increasing
the quality and quantity of the observations (more examinations, tests,
etc.).
3. Prior credences subjective. The
physician may not have formal information of the type encountered in situation 1 but may have strong, intuitively developed measures of prior
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credence based upon experience. Numerical evaluation of these credences
can be evoked but can lead to dangerous conclusions. Polya (1954) and
others warn against attempting it; however, there is no doubt that all practicing physicians act as though they were
making such an evaluation.
4. Minimax prior credences. Consider just two competing diagnoses, H,
and H 2 . Suppose the physician would
take a certain action if the patient had
disease entity number 1 and another
action if the patient had disease entity
number 2. What would be the loss to
the patient if the wrong action were
taken? We can choose prior credences
so that we minimize the maximum loss
to the patient. This approach necessitates very strong observational information before the physician will
depart from the "conservative action."
The idea applies as well to more than
two possible diagnoses.
Most of the current attempts to use
Bayes' Theorem with electronic computers to aid in making medical diagnoses involve situation 1 or 2. Thus,
by situation 1 we replace C(H,), C(H2),
etc. by observed relative frequencies
of the respective disease entities, or by
situation 2 we set the prior credences
equal to each other; that is, C(H,)
C(H,) = · · · = C(H") = 1/k. In either
case we still need to know the second
factors in the mixed Bayes' Theorem,
namely p(B [ H ,), p(B [ H,), etc. We
recall that these factors represent the
probabilities of observing the set of
signs, symptoms, and tests, given that
a particular diagnosis is correct. In
current applications these usually are
empirically determined from the same
population as are the prior credences
of situation 1. That is, these probabilities are replaced by the relative
frequencies of particular sign, symptom, and test configurations in the
various diagnostic cluster groups.
Let us suppose we wish to compare
two competing diagnoses. Let us form
the ratio of p(B [ H,) to p(B [ H,).
When B has been observed, this ratio is
termed the likelihood ratio (LR). By
rearranging Bayes' Theorem we have:

=

LR

=

p(B I Hi) /p(B I H,)

C(H, I B) / C (H,)
C(H2 [ B) / C (H 2)
We then see that the likelihood ratio
amounts to a comparison of the pos26

terior-to-prior credence ratios for the
two diagnoses. If this LR is large we
might wish to favor H , , or if it is small
we might wish to favor H , . The LR
is the basis for the discriminant function techniques mentioned in the last
section, and is the principal idea underlying the procedures adopted in medical diagnosis by Neyman (1947, 1950)
and Collen et al. (1964).
Alternatively, one could employ directly the posterior credence ratio
(CR) given by
CR

=

C (H , I B )/ C (H2 [ B )

That is, if CR is large we would favor
H , , but if CR is small we would
favor H2 . In order to compute CR we
need to specify the prior credences as
well as the likelihoods. This can be
done by appeal to any one of the four
situations enumerated. In particular,
situation 1 has been considered. In
the case of situation 2, the LR = CR
and this has often been used to justify
the LR method.
Conclusions
Armed with an overwhelming accumulation of data about disease, how
can we ensure that they will all be
employed effectively to make a correct
diagnosis in a particular patient? The
use of electronic computers can be
of some help in the collation, correlation, storage, and communication of
the accumulated information, but we
must be careful in instructing the machinery so we will not one day find
a monster whose behavior is unpredictable. A reasonable procedure
would be to analyse our own thought
processes carefully to ascertain how
the human diagnostician arrives at his
conclusions. The matter is certainly
not settled but the concepts of state
spaces and the theory of credences
seem to form a plausible "first model"
of the human inference maker at work
making medical diagnoses. It is hoped
that a wider appreciation of these
ideas will lead to the construction of
better models that could enable the
great potential of the "computer age"
to have its full impact upon medical
care.
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I

" ... What then is a good experiment? It is that which informs us
of something besides an isolated
fact; it is that which enables us to
foresee , that is, that which enables
us to generalize.
"For without generalization foreknowledge is impossible. The circumstances under which one has
worked will never reproduce themselves all at once. The observed
action then will never recur; the
only thing that can be affirmed is
that under analogous circumstances
an analogous action will be produced. In order to foresee, then, it
is necessary to invoke at least
analogy, that is to say, already
then to generalize ....
" ... Thus, thanks to generalization, each fact observed enables us
to foresee a great many others;
only we must not forget that the
first alone is certain, that all others
are merely probable. No matter
how solidly founded a prediction
may appear to us, we are never
absolutely sure that experiment will
not contradict it, if we undertake
to verify it. The probability, however, is often so great that practically we may be content with it.
It is far better to foresee even without certainty than not to foresee
at all."
Henri Poincare, transl. by
G. B. Halsted. The Foundations of Science Lancaster,
Pennsylvania: The Science
Press, 1946, pp. 128-129.
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Gastric Secretion
Mediated

by Extravagal

Neural Influences*
CHARLES H. HOCKMAN AND EBBE C. HOFF

Division of Psychiatric Research, Department of Psychiatry,
Medical College of Virginia, Richmond

Clinical and experimental evidence
amassed in the last 25 years attests to
the importance of cortical and subcortical structures in the control and
regulation of gastrointestinal. funct~on
(Eliasson, 1960). Electrical. stJmulatJ~n
of diencephalic and limbic areas m
experimental animals has been shown
to alter the secretory activity of the
stomach and to produce acute gastrointestinal lesions (Feldman, Birnbaum,
and Behar, 1961a and 1961b; French
et al., 1952; Heslop, 1937; Sen and
Anand, 1957a and 1957b). Studies by
French and his colleagues (French
et al., 1953; Porter, Movius, and
French, 1953) have drawn attention
to extravagal influences evoked by
stress stimuli. These investigators
showed that the stomach can be induced to secrete gastric juice by two
distinct routes. When stimuli were
delivered to the anterior hypothalamus, an early fall in pH was produced
with the stimulus mediating a response
via the vagus nerve, whereas in vagotomized animals, activation of the posterior hypothalamus exerted its influence through the pituitary-adrenal
system, resulting in a delayed secretion of gastric juice.
In the pilot experiments reported
here, evidence is presented which supports the existence of an extravagal
influence upon the elaboration of gastric secretion.
*Supported by Contract Norn 1134(03)
from the Office of Naval Research, and
by U . S. Public Health Service Research
Grant NB 01024 from the National Institute of Neurological Diseases and
Blindness.
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Methods

Eighteen adults cats, weighing between 2.6 and 4.1 kg, were used in
these experiments. Since an earlier
observation had shown these animals
to retain food in their stomachs for
lengthy periods of time, 24 to 48
hours before an experiment glucose
and water were substituted for the
regular diet of the animal.
Under ether anesthesia, a tracheotomy was performed, a catheter inserted into the femoral vein, and the
animal was immobilized with gallamine triethiodide (Flaxedil). Artificial
respiration was maintained with a
Harvard pump. Prior to all surgery
the operative sites were profusely infiltrated with procaine hydrochloride.
In all animals the pylorus was ligated
to prevent regurgitation from the duodenum, and a shortened Levine tube
was introduced into the stomach
through the pyloric sphincter. Following the abdominal surgery, a 5%
glucose solution was infused at the
rate of 8 drops per minute.
In eight animals both blood pressure
and heart rate were recorded on a Sanborn Polygraph. Formvar-coated stainless steel bipolar electrodes (0.010
inch) were stereotaxically placed in
the anterior hypothalamus, posterior
hypothalamus, and central ~ray s~b
stance of the midbrain. The msulatmg
enamel was scraped approximately 0.5
mm from the electrode tips, which
were separated by 1 mm. Two Grass
stimulators delivered symmetrical biphasic pulses (50 cps; 1 millisecond).
Prior to each stimulation the electrode
impedance was measured with a bridge

circuit. The stimulating current was
kept constant at 0.5 ma and was monitored on a Tektronix oscilloscope, and
the stimulus lasted for a 4-minute period.
Gastric juice was collected at hourly
intervals by gentle manipulation of a
hypodermic syringe which was attached to the Levine tube. Volume was
measured and free acid was determined
by titration with NaOH.
In six animals with electrodes previously implanted in the central gray
substance of the midbrain, the spinal
cord was severed at the level of the
second cervical vertbra. Following the
section, a second stimulating electrode
was lowered into the lateral funiculus
of the distal cut end of the cord.
Each experiment usually lasted from
6 to 8 hours. In order to achieve a
baseline for purposes of comparison,
three 1-hour samples were collected
before and after electrical stimulation
of a cerebral locus.
At the end of each study, the stomach was removed and opened along
the line of the lesser curvature, care
being taken not to disturb the position
of the Levine tube. All electrode placements were verified histologically.
Results

The quantity of gastric juice secreted per hour bore no relation to
the animal's body weight. Prior to
electrical stimulation of cerebral loci,
the mean secretion was 1. 7 ml per
hour with a range between 0.4 and
4.6 ml.
Electrical stimulation of loci in the
hypothalamus and central gray sub-

\

stance produced both an increase in
the volume of gastric juice secreted
and in its free acid content. The increase in volume within the first hour
following electrical stimulation varied
from 21 to 200%, the largest increase
in volume resulting from stimulation
of the posterior hypothalamus. An increase in free acid occurred from 1 to
3 hours following electrical stimulation at all loci, ' the increase being
from 50 to 250%.
In two animals with electrode placements in the posterior hypothalamus,
and one with a placement in the
central gray, there were no changes
either in volume of juice secreted or
acid content following electrical stimulation .
Sectioning of the spinal cord at C-2
usually elicited an immediate and copious secretion of gastric juice. Following cordotomy, electrical stimulation
of the central gray substance had no
effect whatsoever upon gastric secretion which was usually inhibited by
the section; however, subsequent stimulation of the distal end of the severed cord, in the lateral funiculus,
elicited a profuse secretion of gastric
juice during the first hour following
the onset of stimulation.
Control animals that did not receive stimulation typically showed a
gradual reduction in hourly volume of
gastric secretion with a concomitant
decrease of acid content in the sample.
In animals in which blood pressure
and heart rate were recorded, electrical
stimulation of the stated loci also
elicited marked arterial blood pressure
elevations, arrhythmic electrocardiographic complexes, pupillary dilatation, piloerection, and urination.
A visual examination of the stomach of all experimental animals revealed irregular hemorrhagic erosions
from one to several millimeters in
length. Although in some animals
these lesions appeared to be superficial, in most they were both mucosa!
and submucosal and were filled with
extravasated blood. The severity of
the lesions did not appear to bear
any relation to the area stimulated.
It appeared rthat, in some animals,
mechanical withdrawal of hourly
samples might account for an irritation of the stomach mucosa, especially
where the rugae came into contact
with the openings in the Levine tube.
A careful examination of the position

of the tube confirmed our suspicion in
some animals.
Discussion

These pilot studies support the results of other investigators by showing
that gastric secretion can be altered
by electrical stimulation of cerebral
loci, and present further evidence for
extravagal control of gastric secretion.
In animals from which blood pressure was recorded, a significant pressor
response was always observed during
electrical stimulation of the stated cerebral loci. This was usually accompanied by other sympathetic phenomena,
including pupillary dilatation, piloerection, and urination. It is noteworthy
that this massive sympathetic activation accompanied the experimental
production of the acute gastrointestinal lesions which were observed. Al··
though some superficial erosions were
undoubtedly the result of the mechanical procedure of sample withdrawal,
we can confidently state that this was
not the case for all lesions which
were observed. We draw attention to
this point since a similar method has
been used by other investigators.
French et al. (1953) and Porter et al.
(1953) have suggested that the extravaQal route for gastric secretion might
be humorally mediated. Although this
possibility is not disputed by the present study, the fact that stimulation of
the central gray substance did not
elicit secretion following cordotomy,
and that subsequent stimulation of the
distal cut end 1of the cord caused an
immediate secretion, would seem to
argue for a more direct neural influence. Additional experimental work in
this area is required in order to permit
an assessment of the role played by
the sympathetic division of the autonomic nervous system in the control
of gastrointestinal function. However,
these results suggest that the sympathetic division does indeed play a role
in the elaboration of gastric secretion.
This raises important and interesting
questions with respect to stress-provoking stimuli and their relation to
psychosomatic disturbances of the gastrointestinal tract.
Summary
In adult cats anesthetized with ether
and immobolized with Flaxedil, the
effects of electrical stimulation of cerebral loci on gastric secretion were
studied. Stimulation of mesencephalic

and diencephalic areas increased both
the volume and acidity of samples collected hourly. Section of the spinal
cord at the level of the second cervical
vertebra abolished this secretion; however, subsequent stimulation in the
lateral funiculus of the distal end of
the severed cord elicited the response.
These pilot studies present further evidence for extravagal mediation of
gastric secretion.
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The Effect of ldoxuridine (IDU) on
Corneal Stromal Cells in Tissue Culture*
WALTER J. GEERAETS, GUY WONG, AND DUPONT GUERRY, Ill

Department of Ophthalmology, Medical College of Virginia, Richmond

An alarming increase in the severity
and frequency of the stromal forms of
herpetic keratitis has been reported
during the last decade (Thygeson and
Kimura, 1957; Thygeson, Kimura, and
Hogan, 1956; Kimura and Goodner,
1963; Bianchetti, 1963). This has led
to an intensive search for therapeutic
means for its management. The introduction in 1962 by Kaufman, Nesburn,
and Maloney of idoxuridine (IDU) as
an effective agent against herpes infection of the cornea has stimulated clinical and laboratory research to evaluate
its full therapeutic potential.
Initially, IDU was reported as favorably affecting the stromal forms of
herpetic keratitis. Kimura and Goodner (1963) and Maxwell (1963) found
this to be true in 50 to 85% of the
cases reported. Subsequently, Payrau
and Dohlman (1964) found that IDU
adversely affected the healing of stromal wounds as evidenced by tensile
strength determinations.
But other investigators (Polack and
Rose, 1964; Kaufman et al., 1964),
basing their results upon the decreased
tritiated thymidine uptake, reported
that IDU only moderately inhibited
the healing of stromal wounds. The
degree to which the decreased tritiated
thymidine uptake accurately reflected
a decreased mitosis has been questioned by Pelc (1963). The same author, as well as other investigators, has
expressed "reservations about assuming an invariable sequential relationship between DNA synthesis and mitotic division." Pelc found that in many
organs a fewer number of cells divided
than would be expected from the number of labeled cells found, thus indicating that DNA can be replaced in a

* Supported, in part, by the Virginia
Lions Organization through the Old Dominion Eye Bank and Research, Inc.,
Richmond.
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cell nucleus without cell division taking
place.
Since the complete effect of IDU on
corneal cells is still not known, this investigation was conducted. During the
experimental phase of this study, a few
studies in vivo appeared in the literature (Kaufman et al., 1962; Maxwell,
1963; Kaufman et al., 1964; Ey,
Hughes, and Holmes, 1964), as well as
tissue culture work with various cells.
However, to our knowledge, no study
in vitro with corneal stromal cells has
been reported, although it has been
pointed out (Kaufman, personal communication) that the effect of IDU
may vary with the cell type used.
Materials and Methods

Cell Culture
Corneal tissue cultures were used.
Corneal explants were obtained from
chinchilla rabbit eyes and cultured under perforated cellophane in growth
medium (minimum essential medium),'
with L-glutamine (3 mg per ml), penicillin (100 µ, per ml), streptomycin (0.5
mg per ml), and 10% calf serum. The
pH was 7.4 which equilibrated with
5% C02 at 37 °C.
A cell strain of corneal stromal cells
which had undergone at least eight
passages was obtained and used in this
experiment (fig. 1).

ldoxuridine Medium
Growth medium containing idoxuridine was prepared by dissolving powdered IDU2 in the medium. First, a
1,000 µ,g per ml solution was prepared.
One-tenth dilutions ranging through
0.1 µ,g per ml were then prepared. This
material was filtered through Seitz fil' Grand Island Biological Company,
Grand Island, N.Y.
2 Nutritional
Biochemicals Corporation, Cleveland, Ohio.

\

Fig. I-Corneal stromal cells in tissue culture (220 X).

ter pads before use. The medium was
kept in the dark at 4 °C and all had
been used 2 weeks from preparation .
At the end of the study, the medium
was cultured for aerobic and anaerobic
organisms and fungi and was found to
be sterile.

Cell Count
The cell cultures were washed twice
with 4-ml portions of salt solution of
the following composition: 8 gm of
NaCl, 4 gm of KC!, 1 gm of glucose
per 1,000 ml. To each plaque bottle
0.5 ml of 0.25 % trypsin-0.2 % Versene
solution was then added. This solution
was allowed to act for 8 minutes. The
bottles were shaken every 2 minutes
and examined microscopically to determine whether the cells were adequately

'"'t dod.

Deoctiv.tioo of tho my-

matic chelating solution was achieved
by adding 1.5 ml of growth medium.
The cell suspension then was passed
through a number 25 gauge hypodermic needle. The cells were counted at
once in a hemocytometer. Six to ten
samples were counted from each bottle
to establish the average number of cells
with the more dilute cell suspensions.

Procedure
With the foregoing materials and
technics, IDU's effect on stromal tissue
culture cell growth was studied. In this
experiment, 72 plaque bottles (surface
area of 15 cm2 ) were plated with equal
aliquots of a cell suspension. Twentyfour hours later, when the cells had
been allowed to attach to the glass, a
cell count was determined in 18 bottles
selected at random. This value was
31

considered to be the number of cells
attached to the glass at zero time
(29,700). The remaining 54 bottles
were divided randomly into six different groups. These cell cultures were
subjected to "!DU-media" of concentrations of 0, 0.1, 1, 10, 100, and 1,000
µ.g per ml. The media were changed
daily and cell counts were determined
at the end of 72, 120, and 168 hours
following exposure to IDU. The experiment was carried out in triplicate:
thus, three bottles from each group
were counted at the end of each of the
above periods. The total experiment
was repeated with a different strain of
stromal cells, leaving other variables
unchanged.

TABLE 1

Total Number of Cells in Each Bottle after Various Periods of Exposure to Different Concentrations of IOU

Exposure to
IDU for
hr

Results

The control bottles contained an average of 92,900 cells per bottle, while
the cell population treated with the
lowest concentration of IDU (0.1 µ.g
per ml) contained a mean of 51,900
cells per bottle (table 1 and fig. 2). This
difference proved to be statistically
significant at the 0.01 level.
The cell count of the cultures treated
with 1, 10, 100, and 1,000 µ.g of IDU
ml medium revealed 28,400, 25 ,000,
20,000, and 18,900 cells per bottle, respectively. These counts were of significant difference regarding the control group as well as the cells exposed
to 0.1 µ.g of IDU per ml of medium.
The level of significance was 0.05 or
better. The number of cells treated
with !DU-media, ranging from 1 to
1,000 µ.g per ml, revealed a decreasing
number of cells with increasing concentration of the IDU. However, these
slight differences were not significant
as these counts were below those of
time zero (29,700).

120 Hours
The cell count of the control bottles
revealed an average of 215,000 cells
per bottle; the bottles treated with 0.1,
1, 10, 100, and 1,000 µ.g of IDU per
ml had a mean of 102,000, 42,200,
33,800, 24,800, and 18,900 cells per
bottle, respectively. The number of
cells in the control group compared to
the treated groups was found to be sig32

0 µg
IDU/ ml

0.1 µg
IDU/ ml

1 µg
IDU/ ml

10 µg
IDU/ ml

100 µg
IDU/ ml

1,000 µg
IDU/ ml

0

29,700

72

94,900
106,000
77,700

67,200
38 ,000
50,600

39,400
25,800
20 ,000

22,000
22,000
30,900

23,400
20,600
15,900

26,700
14,500
15,500

120

236,000
194,000
215,000

154,000
101,000
49,700

35,200
65 ,700
25 ,800

23,900
41,300
36, 100

18 ,300
21,600
34,500

26,700
15,000
15,000

168

471,000
436,000
480,000

83,300
67,700
115,000

50 ,300
32,700

22,000
35,200
38,700

30,500
35,600
30,000

15,500
17,800
22,000

The observations made at the end of
the three different interaction periods
of IDU on cultured corneal stromal
cells (72, 120, 168 hours) are described
separately for each period.
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Fig. 2-Graph representing multiplication of corneal stromal cells in tissue culture
without (control) and with IDU present in the culture medium (0.1 to 1000 µg per ml).
nificant at the 0.01 level. There was
also a significant difference of the cell
number of those cultures exposed to
the weakest concentration of IDU (0.1
µ.g per ml), and those treated with
higher IDU concentrations (1, 10, 100,
and 1,000 µ.g of IDU per ml media) at
a level of 0.05 or better. Similar to the
72-hour observation, the cell number
decreased with the increase in IDU
concentration. The difference between
the cell counts in these experimental
groups was of no significance statistically.

168 Hours
The difference between the number
of cells in the control group compared
to those of the treated groups was even
more pronounced than for the time intervals of 72 and 120 hours of exposure to IDU. The control group showed
a 15-fold increase in cellular population (29,700 at time zero versus 462,000 at 168 hours). In contrast, the
weakest concentration of IDU in this
experiment permitted only a 3-fOld increase in the cellular population\~ur
ing tho "m' period (29,700 .i \ m'

zero versus 88,900 at 168 hours). This
3-fold increase in the number of cells
of the latter group again was significantly different from the populations
treated with the greater concentrations
of IDU. This was found at the 0.01
level.
As was noted in the group of shorter
exposure to IDU, there was only an
insignificant difference found between
the number of cells in the 1, 10, 100,
and 1,000 µg of IDU per ml of mediatreated populations, all which showed
cell counts similar to those at time
zero.
Throughout this experiment, there
was no significant difference in cell
counts within individual groups that
could have been attributed to the different periods of IDU exposure. Thus,
IDU interaction upon corneal stromal
cells for 72, 120, and 168 hours in
equal concentrations did not result in
significantly different cell counts.
When the total experiment was repeated with a different strain of stromal cells, the results obtained were
very similar to those above.
Discussion

The marked inhibition of cell population increase and its relation to the
concentration of IDU is consistent with
recent observations by others. The
growth inhibition of mouse leukemic
cells in culture by IDU was reported
by Mathias, Fischer, and Prusoff
(1959). These authors reported that
IDU, at ordinarily accepted therapeutic concentrations and less, permitted
only a single doubling of the population cells in culture, and thereafter
"cell death invariably commenced."
Ey, Hughes, and Holmes (1964)
found that, with concentrations of
IDU at less than therapeutic strength,
the multiplication of primary rabbit
kidney cells in culture was entirely
blocked. Cheong, Rich, and Eidenoff
(1960) have reported similar results
with cultures of human cervical carcinoma cells.
Studies in vivo by Polack and Rose
(1 964) with therapeutic doses of IDU
illustrated that there was a delay in cell
repopulation after stromal injury in
rabbits. Payrau and Dahlman (1964)
also found that stromal wound healing
was retf(rded in rabbits treated with
IDU. As was theorized by Polack,
"this inhibition should increase if IDU
ooul/ ' m>de mifable to fill the p<e-

mitotic cells." The more marked quantitative differences in cell counts, after
exposures to various concentrations of
IDU in this study in vitro, can be based
on this assumption of Polack.
The arrest of cellular multiplication
after exposure to a critical concentration of IDU may be explained by lysis
of the cells. Mathias and Fischer
(1959) found that murine leukemia
cells in 10- to 100-µg IDU solutions
underwent lysis even after doubling in
number.
The findings reported in this study
suggest that the proliferation of corneal stromal cells is inhibited by IDU.
These findings in vitro should be considered when IDU is clinically used in
cases where there is severe stromal involvement.
Summary

Corneal stromal cells were cultured
in vitro and exposed to various con-

centrations of idoxuridine (IDU), ranging from 0 to 1,000 µg of IDU per ml
of medium. Inhibition of cell multiplication occurred with concentrations
of 0.1 µg per ml. With concentrations
of 1.0 µg per ml and greater, there was
no increase in cell number from the
time of exposure to IDU.
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The Challenge of Pulmonary Emphysema*
DAVID V. BATES

Department of Medicine, Royal Victoria Hospital
McGill University, Montreal, Canada

I feel very privileged to be invited
to be your Stoneburner Lecturer for
this year. When I came to consider
what I really wanted to say and what
might interest people in widely different areas of medicine, there really
was little choice. I perhaps can claim
to be able to talk about emphysema
from a rather broader standpoint than
some other physicians. Not because I
suffer from it, which is sometimes a
good reason for talking about a disease, but because I have been trained
both in England and in America, and
the outlook on this disease has differed
in Europe and in the States.
I started work on emphysema under
the guidance of Dr. Christie in 1948,
and in 1948 no one was much interested in the disease. I worked in Philadelphia in 1952, and there I gave a
lecture on emphysema which was so
controversial that it was disbelieved.
The climate is different now, and I
am talking about something of which
most of you already know a fair
amount. I have selected it as a topic
because, whether you are a public
health administrator, an internist, an
allergist, an anesthetist, a surgeon, or
even just a cigarette smoker, you
should be interested in this condition.
One reason for contemporary concern about this disease is the considerable increase in the standardized mortality in the United States since 1945,
for what physicians call on the death

* Presented as the first of the Seventeenth Annual Stoneburner Lectures at
the Medical College of Virginia, March

certificate "emphysema and fibrosis."
The rate of increase of lung cancer
has been similar, but since 1955 the
diseases categorized as "emphysema"
have been increasing more rapidly
than has lung cancer. Over the same
period, of course, mortality from tuberculosis has dipped. But the puzzle
of nomenclature can be seen from
the fact that bronchitis, as certified in
the United States, has apparently not
increased at all as a cause of mortality.
If I were to show you a comparable
graph from Europe, bronchitis would
appear to h ave been the main cause
of the increased mortality, and emphysema to a much smaller extent. I
think we now realize that this is purely
a semantic matter. Differences are
not great between different industrialized communities in any of these diseases. It has been largely a matter of
what the physician has called the
condition he has looked at.
Certified causes of death at best
are enigmatic and subject to shifting
classification. The autopsy incidence
of morphological emphysema as found
in 138 random autopsies of inflated
right lungs at the Massachusetts General Hospital in Boston has been reported by Dr. Thurlbeck. With reference to men only, and by dividing the
autopsy population into 12 decades
of age, the incidence of quite obvious
morphological emphysema, excluding
the little bits of emphysema at the
apices and other minor forms, is striking. Once men are in the fifth and
sixth decades, half of the random au-

11, 1964.
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morphological emphysema. The same
data in identical form are found in my
own hospital in Montreal. So Montreal
and Boston have a virtually identical
autopsy incidence. Many pathologists
have emphasized that the true incidence of emphysema can only be evaluated if the lungs are inflated. If they
are fixed when collapsed, he will underestimate the incidence of this condition by at least half; and second, he
will not be in a position to see, as I
will show you in a few moments, its
most damaging form. When the Massachusetts General Hospital group is
broken down into categories, the malefem ale incidence is very different.
In 59 females, 45 had no detectable
morphological emphysema. In 79
males, only 25 had no emphysema.
This reflects the 4: 1 prevalence of
emphysema in men.
There is another reason why this
group of diseases has become very important. You will recall the major episode of smog in London in 1952, but
you may have forgotten that this episode killed 4,000 people in 6 days. The
smog lasted from December 2 until
14, approximately. London is so large
that it took the Registrar General's
figures 3 weeks to catch up on the
surplus mortality of 4,000 people. So
this is another reason why this disease
has become important.
The First Challenge

The first of emphysema's three challenges is to understand not what the
acute episode can do, which we know
very well in a population with some

I

lung disease, but to understand what
lesser degrees of atmospheric pollution
do, not over 6 days but over 20 years.
I fancy it will be a long time before
we understand the interrelationship
between the acute sensational phenomenon and the chronic unsensational mortality.
I grew up in an era when chronic
bronchitis did not have a respectable
pathology. In Boyd's Pathology for
1947, chronic bronchitis was not a respectable disease. It was mainly an
important complication of tuberculosis, or it was sometimes a nuisance in
people with heart disease, but as a
primary pathological entity it was
little regarded. It is worth reminding
you that now it has a highly respectable and extremely carefully quantified pathological existence, depending
on hypertrophy of the bronchial mucous glands.
Now it is time we took up some
practical examples of the kind of patient you deal with, and we deal with.
I am not going out of my way to
speak of the only case I have seen in
5 years that represented so and such.
I am talking about things that I believe are extremely common. The first
patient was a 66-year-old man who
worked all his life with the Canadian
Pacific Railway, largely an office job,
and gave a rather clear history of
some breath shortness for 2 years,
some chronic cough for perhaps 15
years, not very much sputum, and an
occasional episode of respiratory infection. He had dyspnea for 1 year.
The function tests were done when he

had one such episode while in another
hospital. He had left that hospital diagnosed as having arteriosclerotic heart
disease. They found an abnormal EKG ,
swollen ankles, liver two fingersbreadth's enlarged, and a normal chest
film. When he was studied in the function lab in November, 1958, the findings were: a vital capacity about half of
what it should be, a lung volume much
bigger than it ought to be-gross overinflation, and markedly uneven gas distribution. The F.E.V. (forced expiratory volume) should have been 70 L per
minute, but was only 19 L per minute.
His airflow rate should have been 3 L
per second, but was only 0.2 L per
second; therefore, he had terrible ventilatory obstruction. The transport of
carbon monoxide, or the diffusing capacity, should have been about 14 and
was 7 ml per minute per mm of Hg.
This tells us either he had very uneven ventilation/ perfusion distribution
in the lung, which is commonly found ,
or he had a reduced surface area for
gas exchange, or a thickened alveolar
membrane. His arterial C02 tension
was 56 mm of Hg, and the pH 7.4. You
know, therefore, this was a chronic situation because he had brought his bicarbonate up to adjust the pH. The
oxygen saturation was a little down.
About 9 months after these tests were
done he came to the hospital with a
very severe pneumonia, and he died
as a tracheotomy was being done. The
whole lung section of this man show,ed
black areas which look at a distance
like currants. These are holes which
35

go from the bottom to the top. They
can be better shown if you outline the
normal lung with barium (fig. 1). You
are now close to what killed him, an
example of severe widespread centrilobular emphysema. Each of these
holes is roughly in the center of the
lobule, and around it is an area of remaining normal alveoli. Virtually no
lobule anywhere in either lung is
spared. When this lung was allowed to
collapse and sectioned in the normal
way, it was reported as being normal.
This lesion is exceedingly hard to see if
you allow the lung to collapse. When
these holes collapse, they approximate;
the alveoli in between are normal, and
the pathologist, by allowing the lung
to collapse, has put himself in the
worst possible position to see the lesion responsible for the disease. It was
Gough in Cardiff who separated out
this form of emphysema from others.
He called it centrilobular emphysema.
It is a good name and it was the first
step forward in differentiating the pathology of this disease. One of the
mysteries of emphysema is why this
is such a lethal condition. The man I
showed you had normal coronary arteries. His right ventricle was hypertrophied and not his left. (He had no
arteriosclerotic heart disease although
this had been diagnosed.) The only
thing he died of was his severe CO,
retention, which came upon him when
he got pneumonia. However, he had
had hypercapnia chronically for several years. The mystery is why this lesion, which can be quite minimal and
unspectacular, so often gives rise to
such severe blood gas disturbance.
The Second Challenge

FIG. I-Whole lung section from patient
with centrilobular emphysema. Barium
added for clearer demarcation.
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This brings me to challenge number
two; that is, to understand much more
fully than we do at the moment the
interrelationship between the structural changes, which the pathologist
can picture, and the functional derangement responsible for the patient
getting to the pathologist at all. This
is something which many people are
working on, and I can only present
you with the problem and stimulate
you to this extent: that there probably
is no disease of an organ as big as the
lung in which 75 % of the alveoli can
be intact, and yet in which you die
from its consequences. There must be
something then about the situation of

this lesion in the middle of the lobule
at the end of the bronchiole which is
particularly harmful. It is remarkable
that you cannot get along with 25%
of your lung gone, if it happens that
this destruction has occurred at the
end of each terminal bronchiole.
There was a period in which people
used to chat about the tremendous reserve of the lung. They said you could
take one lung out of a man and he
could walk upstairs. That is fine . He
can, but you punch out the center of
each lobule and he has a very limited
prognosis.
My second example is of a man
about the same age as the previous
man, to illustrate the clues you can
get in life that the lesion is centrilobular emphysema. This man's pulmonary
function tests were similar to those of
the first patient, also showing severe
ventilatory defect and hypercapnia
(table 1). This man happens to still be
alive. But I wanted to mention him
because of his chest x-rays (fig. 2a) .
In the close-up of a carefully taken
bronchogram, where plenty of time
was allowed for the material to get
into the pools, the major bronchi are
fairly normal, but when it gets to the
periphery it fills the pools. Simon and
Reid have called these the "Lily of the
Valley" sign, as the total picture is
rather like a lily of the valley (fig. 2b ).
If you will take a lung with centrilobular emphysema and inject it in
the autopsy room, you get a very similar picture. There is a hole, and furthermore there is considerable distortion of bronchi. The pool is filled at
the end. So you can get a clue from
bronchography. As I will show you in
a moment, there is quite a different
sort of emphysema which clinically
may be almost indistinguishable from
this one.
I am not going to talk in this lecture about details of technique of
study, because these are of interest
only to people working in this field. I
am going to take a jump, however, to
describe briefly a technique, because I
want to show you what you may learn
with it. I am not going into great detail. The point I want you to get is
the result. The research group with
whom I work has been busy for 4
years working on what may be learned
by studying how the lung handles radioactive xenon. Xenon is a radioactive gas that you can breathe in very
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safely, and measure from outside the
chest what the lung is doing with it
(fig. 3). A subject having such a study
has behind him six scintillation counters, positioned in particular places in
relation to the chest x-ray, three on
one side and three on the other. With
this method, you can get an idea of
what each bit of the lung is doing;
sometimes, as I will show you, with
very surprising results. Then you can
use it another way. You can dissolve
xenon in saline and put it in the arm
vein, and watch its clearance into lung
alveoli. Of what gets to an alveolus,
95% will be cleared into the gas phase.
I think it is quite obvious, without a
lot of mathematics, that in this way
you can quantify the ventilation which
each lung zone is getting, and its
blood distribution, as shown by this
study. A complete examination of the
kind I have very briefly described
gives you rather less than one-half the
radiation of a single chest film, so
there is no serious radiation hazard in
the use of this particular isotope.
Now I am going to show you what
happens if you do this very simple experiment. It takes a few minutes of
the patient's time and a lot of instrumentation, but you can learn a lot
from it. Figure 4 shows the three
counter positions on each side-six
rings where the counters were positioned on this patient. The patient is a
46-year-old woman who had been com-

FIG. 4-Location of xenon counters in
relation to chest film.

TABLE 1

Pulmonary function report of Mr . A. H . M., age 61 , who had minimal sputum for
IO years (<IO cc per day) and dyspnea on exercise for 5 years.

Vital capacity . . . . .
. .. .. .. . . .
Functional residual capacity ... . .. . . . .. .
Mixing efficiency . .
. ... . .. . . .. . . .. ...... .
Forced expiratory volume... . ...... .. . . . . . .. . . .
Maximum midexpiratory flow rate ..
Arterial
pC0 2 ••••

• • • • •..

pH .
HCO'a.
Resting CO diffusion .

2 .1 L
5.4 L
37%
19 L/ min

0.24 L/ sec
58 mm Hg

7.4

34.5 mM/ L
5.3 ml CO/ min X mm Hg

Fm. 2-Chest x-ray (a) and bronchogram (b) of patient A. H. M.

Fm. 3-Xenon scintillation counters in position.
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plaining of breathlessness for 2 years.
She had never smoked more than two
cigarettes a day, and she never had any
sputum, not even enough for a specimen. When she became dyspneic, no
one really would believe her. The
chest film was thought to be normal;
physical examination of the heart was
normal; the electrocardiogram was
normal, and the blood pressure was
normal. The only thing was her repeated statement that she was short of
breath. The physical signs of the lungs
were minimal. I think the only thing
to make you suspicious was that the
breath sounds were a little hard to
hear in someone who was quite thin,
as she weighed only about 105 pounds ;
she had lost a bit of weight. She was
so incapacitated with dyspnea that she
could cook standing up at the stove
only with difficulty. Of course, the
consequence of the combination of
these findings is that you get referred
to psychiatry. This she had for 6
months without noticeable benefits,
except that her own views on psychiatrists became much better defined
than they had been in the past!
Comparing predicted values for a
woman of this size and age, as we have
in three series of studies (table 2), you
can see how consistent the pu!mcnary
function findings were. Her vital capacity final!y came down to 900 ml.
The lung volume initially was not big,
but became bigger. The total lung
capacity was about correct. The gas
distribution was very poor. Her venti1ation was appalling, maximum midexpiratory flow rate, unaffected by
bronchodilators, very bad indeed. The
resting diffusing capacity was onethird normal, and on hyperventilation
we managed to get a reading of 5.6.
This told us that something was very
badly wrong with distribution and gas
exchange. However, there was no C02
retention , and the oxygen saturation
was not strikingly abnormal. This is the
kind of case one should show all residents from the start, since the arterial blood can be a bad indicator of
pulmonary abnormality. You can be incapacitated for years and have normal
arterial blood. It is often misused in
practice by people who have not had
enough experience with these diseases
who place too much reliance on this
as a test of function. It is very important to know it, but it is very important not to place too much dependence
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FIG.

5- Section of right lower lobe from patient L. B., showing panlobular emphysema.

TABLE 2

Pulmonary function report of Mrs . L.B., age 46. See Fig. 4 for x-ray.
Pre- April ,
dieted 1958
--- -

Vital capacity (L) .
.. .
Functional residual capacity (L). .. .
Total lung capacity (L) .
Mixing efficiency (3) .
Forced expiratory volume 0 75 X 40 (indirect maximum breathing capacity) (L/ min).
Maximum midexpiratory flow rate (L/ sec) . .. . ..
Resting CO diffusion (ml/ mm Hg X min ) . . . . .
Arterial blood
pH
. . . . . . . . ' . . . . . . . . . . . . . . . . . . .. . . .
pCO, (mm Hg) . . . . . . . . . . . . . . . . . . . .. . . .. . .
0 2 Hb saturation (3).
. . . . . . . ... .. . .. .

May,
1960

April,
1961

-- --- ---

2.8
1. 3
2.6
2.6
4.2
3.4
: 22
60

1. I
3 .1
3.8
37

0 .9
3.5
4.1
17

76
3.7
14.0

13
0.17
4.6

15
0.20
4.3

11

7.4
40
94

7.42
40
90

7.41
43
95

7 .37
40
91

0. 15
4.4

TABLE 3

Xenon 133 distribution indices of Mrs. L. B.
Right

Left

Upper

Mid

Lower

Upper

Mid

Lower

Tidal breath . ... . . . .
Predicted. .. . . ... .

139
58

33*
70

12*
87

88*
57

29*
70

106*
91

Perfusion . .... . . ..
Predicted.

249
38

69
70

79
67

86
129

61
137

278
42

* Abnormally slow clearance observed from these sites.

on it. I will show you why this woman's arterial blood was normal, because it is quite clear when you see
where the ventilation and perfusion
were going, that they were fairly accurately matched. It is worth stressing
that you can be in a desperate situation
from a ventilation point of view for
years, without any change in the arterial blood. This is another part of the
challenge of relating structure to function.
(Table 3) Now, the xenon technique
I showed you ends up as a series of
numbers, and I am not going into the
derivation of these numbers; we call
them distribution indices. Their magnitude is not very important, but they
tell us the amount of ventilation going
into different portions of one lung and
the other. What I want you to notice is
that, on simple tidal breathing, instead
of there being slightly more ventilation
in the lower than the upper, on the
right side there is a 10-fold difference,
and perfusion distribution on the right
side is also reduced. Almost all the perfusion is going through the upper part
of the right lung, and much less in the
lower. As you sit there, upright, which
is the position she was studied in, you
have about four times as much perfusion through the lower as the upper, so
that in normal subjects the upper zone
counter is about 60, and in her it was
about 150. There is much better ventilation in the left lower zone. It is
much better, in fact, than the left
upper. However, we have the same
imbalance of blood distribution, so
that we now know what we never
would have guessed from the chest
film, let alone from the stethoscope,
that the right lower zone has grossly
impaired ventilation and perfusion.
Presumably this is one of the main
areas that has been destroyed. With
these people who have been almost
entirely incapacitated for years who
are below the age of 50, we have on
occasion taken out lobes that are doing nothing. Figure 5 shows what her
right lower lobe looked like. This was
a completely destroyed lobe. It was
destroyed this time not in the centrilobular fashion showed in the first
patient, but generally destroyed. This
often is referred to as panacinar or
pan lobular
emphysema.
Already,
therefore, we have made a differentiation. This is a youngish woman with
very little smoking history, virtually

no bronchitis, and at least one lobe of
her lung, and probably the left lower
as well, has been destroyed. At operation, the right upper looked normal,
but I do not believe it was completely
normal. We got m arginal improvement in function by taking out the
lower lobe. She was just able to go
out and walk around the block. She
is still alive. The blood gases are exactly as they always were. To return
to that point about the blood gases,
when one lobe, in her case the right
upper, is getting most of the ventilation and most of the perfusion, there
is no imbalance. The lung manages to
keep the arterial blood normal, but
half the right thorax is occupied by a
lobe which is idle in terms of ventilation and perfusion. It was because we
believed then, as we do now, that this
destroyed lobe in some circumstances
can interfere with the ventilation of
the more normal lobe on the same
side that the lobectomy was performed.
I wanted to show you a similar
situation in a man of about the same
age. If you study chest x-rays and
tomograms carefully, by looking very
carefully at the vasculature, you can
get some idea where the blood is going. Figure 6 shows the angiogram of
a patient in whom radioactive xenon
studies were performed. These showed
that the left upper zone was getting
about five-sixths of both ventilation and
perfusion. It was all he had to live on.
He had been incapacitated for 4 years.
The angiogram shows clearly the predominant perfusion of the left upper
zone. If the pathological differentiation
were as clear-cut as I h ave just made
it, we would be on very good ground.
But that isn't so. Often these two lesions occur together in the same lung.
This is a commonplace finding when
you look at autopsy m aterial. Before
one gets fancy about differential etiology, it is important to remember
that whatever theory you construct
may have to explain the simultaneous
incidence of the two lesions in the
same lung.
One of the points of the radioactive
xenon technique is to see whether it
can tell us not only what one lobe, or
zone, is doing in relation to others,
which is an interesting thing to know,
but also whether, by some refinement
or trick, it can tell us anything about
the distribution of blood and gas oc39

FIG. 6-Angiogram of patient with pan-

lobular emphysema. The upper lobes are
relatively spared.

curring within a specific zone. Although we have gone only a little way
with this kind of differentiation, it is
worth mentioning. We are trying to
develop means of measuring effective
ventilation within zones or counter
fields, in the hope that differences may
reflect varying pathological types of
emphysema. We think this may become very important because it seems
to us that the pattern of centrilobular
emphysema usually has this kind of
imbalance. This is the first clue we
have had in 10 years of work that
might get us closer to the differential
function of these different types of
emphysema.
The Third Challenge

FIG. 7-Chest film of a young asthmatic.
X-ray alone could lead to a mistaken diagnosis of emphysema.

Now, my third challenge in emphysema is, of course, to the clinician.
It is to challenge him to be able to
differentiate in life between bronchitis, asthma, and emphysema. It is
really a challenge to get close to the
morphology of the lung of the patient
he is treating. In other words, how
can he find out what the morphology
was like, not merely afterward when
we have the lung to look at, but during
life? Most physicians would agree that
this is very difficult. It is very difficult
in the Jung because the x-rays are,
with some exceptions, of rather little
value. The physical examination is almost worthless and is as often misleading in terms of differentiation as
it is helpful. By that I mean, that if
the chest is barrel-shaped, I still don't
know what's happening to the Jung
underneath. Not only do I not know,
but I know that y ou don't know, and
no amount of talking on the chest

contour in relation to lung morphology will convince me that you can do
very well with a tape measure, or
standing and looking at the plain x-ray
film. The better pathologists you have,
the worse you will find you are doing.
One kind of x-ray is often diagnosed
in x-ray departments as indicating
emphysema. The one in figure 7 belongs to a radio weather forecaster,
so that if I listen to the weather forecast in the morning at half-past seven,
I can hear whether he's wheezing.
He's a young man of 28. He has a
clear history of allergy in the family,
suffers from hay fever, and is an asthmatic; never very severe but never
completely free of bronchospasm. The
plain film could easily deceive a radiologist into thinking this might be
destroyed lung. On examination in the
pulmonary laboratory (table 4), he
had an impaired vital capacity. His
lung was somewhat over inflated, as
the residual volume is a 1,300 ml too
big. The ratio of residual volume to
total lung volume, which some people
like to think of as a measure of emphysema, was elevated. The gas distribution was poor, the ventilation was
diminished, and the maximum midexpiratory flow rate was quite considerably down. The resting diffusing
capacity, however, was above normal.
When you see this phenomenon of a
normal diffusing capacity by a steadystate method, you can go out on a
limb and say you never have that kind
of diffusing capacity when your lung
parenchyma is destroyed. That is the
only way you can really use it. When
it's like this, regardless of how bad
the ventilation is, regardless of how

TABLE 4

Pulmonary function report of Mr. F. E., age 28, who had spasmodic asthma.
Blood gas tensions were normal. Xenon studies: slight prolongation of wash in
and washout in all zones; normal indices of perfusion and ventilation distribution;
no disparity between clearance of " ventilated" and " perfused" lung.

Vital capacity (L) ...
Functional residual capacity (L) . . .. .. . . . . .
Residual volume ... . .... .
Residual volume/ total lung capacity (% ) . . ... . . . .. .
Mixing efficiency (%) .. . .. .. . . . ........... .
Forced expiratory volumeo.75 X 40, (indirect maximum
breathing capacity) (L/ min) . . .
Maximum rnidex piratory flow rate (L/ sec) .... . . . . . . . . .
Resting CO diffusion (ml/ min X mm Hg) .. .
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Predicted

Observed

5.6
4.2
2.0
26
65

3.4
3.8
3.3
49.5
34

140
4 .50
23. 5

83
1.30
33 .0

bad the gas distribution is, you'll never
lose your money if you bet on a normal parenchyma. Of course such patients rarely get to pathology, so you
don't win much because these asthmatics do not tend to die. But this
tells you his lung parenchyma must be
intact, regardless of what the x-ray
department thinks. When you study
such a man with a single breath of inspired xenon, you find that his regional gas distribution is normal. He
has no gross change in perfusion distribution either. But when you study
him on a steady state experiment, you
find in this particular man that the
right upper and lower zones have a
very considerably impaired ventilation. I show him because I don't know
why his asthma is not a uniform phenomenon. I don't know why it has
singled out two zones, but this appears
to be a common feature in asthmatics.
It is important to stress that spasmodic
asthma does not of itself give rise to
emphysema. They are utterly and
completely distinct phenomena. In
terms of xenon distribution, asthma
does not appear to cause the kind of
gross upset of perfusion distribution
you commonly see with a destroyed
lobe, nor does it cause the imbalance
between ventilation and perfusion
clearance you may see in centrilobular emphysema. What it does cause is
regional ventilation impairment without much change of perfusion. There
is an upset of ventilation-perfusion
distribution, but it is a consequence
of the ventilation change, the perfusion being very much as normal.
In this differentiation between emphysema and asthma, there is one important bit of evidence I have not
dwelt on or shown you anything
about. That is, in emphysema, at a
certain lung volume, which we'll say
is 4.5 L, the transpulmonary pressure, or the pressure between the
esophagus and the mouth, is much less
negative than in normal people. Asthmatics, however, whether over or under 20, follow more or less the normal
curve for lung recoil. If you destroy
alveoli, you cut down the normal recoil of the lung, which is quite a useful way of knowing whether you are
looking at an asthmatic lung with a
normal recoil, or whether you're looking at one which has destroyed alveoli. This simple test is not used
anything like enough, and we have

evidence that it very rarely lets you
down.
There must be 15 theories of the etiology in emphysema and you are quite
entitled to take your pick among
these. It is probably as good as anyone else's pick. But that is not really
the question we can yet ask. We have
to be sure we are looking at one condition. We have to be sure that we
have refined our understanding of the
relationship between the structural
change, which the pathologists can
show us, and the function defect, as
far as we can. Only then can we talk
meaningfully about differentiations in
this disease in life. And when the
practicing physician is faced with a
man of 45 with a chronic cough and
a good deal of dyspnea, he is challenged to predict what the lung is like.
Until he seriously tries to do this, it's
extraordinarily hard to realize how
bad the methods are at his disposal
to make any differentiation between
bronchitis with airway obstruction,
asthma with spasmodic airway obstruction, often chronic (both of those
having an intact lung parenchyma),
and the differing kinds of emphysema.
Only if he is worrying about the vascular pattern of the lung, only if, with
the support of the function Jab, he is
moving a little closer to excluding
people from one or another category,
can he really get a perception in his
own mind of how good or bad he is
at making this kind of clinical differentiation. This distinction is not
merely of academic interest. It is absolutely cardinal in understanding the
interrelationships of these diseases and
guessing intelligently at their etiology.
There is never any excuse for sloppy
clinical thinking; there is surely every
reason to encourage people to sharpen
it to the maximum. The first thing you
learn when you try to predict accurately the morphology of the lung in
people, and follow them over a long
period of time, is that in this main endeavor, we have hardly yet begun.

"It is surprising, perhaps, to realize how many people at one time
or another exert some sort of medical function. The old-world grandmother who nursed a dozen cases
of measles in her own children does
not hesitate to make a diagnosis
on her young grandchild, nor to
tell her daughter precisely what to
do. The arthritic may sing the
praises of flannel cloths and goosefat; the newspaper editor may
freely recommend a "reducing
diet," and the pharmacist a sleeping-pill or headache remedy. Laymen who give such advice are
relying on experience. Often the
advice seems to work, perhaps not
perfectly, but at least to a gratifying degree.
"Many laymen have been extremely skilled in diagnosis and
have achieved considerable therapeutic success. However, giving
appropriate advice is only part of
medical skill-an important practical part, to be sure, but still only
a part. The layman can learn from
experience what to do, but the physician must also know why he does
what be does. He must know it in a
manner quite detailed, clear and rational, organized and logical. It
is this knowledge which sets off
the physician from the layman ...
Aristotle made the distinction quite
explicit, that almost anyone can
learn
procedure
empirically,
through rule of thumb, but whoever lays claim to scientific knowledge must know the reasons and
the general principles."
Lester S. King, The Growth
of M edical Thought. Chicago: The University of
Chicago Press, 1963, pp.
1-2.
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I suppose it is appropriate that we
come to respiratory failure at the end
of a longish day. The definition of respiratory failure has an interesting history. Barcroft, 30 to 40 years ago,
understood respiratory failure as a
tissue phenomenon. He would have
described cyanide poisoning to you as
an example of respiratory failure.
"Ventilatory failure" came into fashion but is not a very good term because total ventilation may be fine but
gas exchange may be very poor. Europeans have invented various terms
like "global insufficiency," which
sounds very impressive in German,
but always sounds to me more like a
term from the Pentagon than a medical or physiological definition. I prefer
to use the term "respiratory failure"
to mean everything related to disordered gas tensions; but if you attempt a precise definition, you run
into unexpected difficulties. If you
define it in terms of blood gases only,
you will call patients with an arteriovenous fistula in the lung sufferers
from "respiratory failure," which is
nonsense. You would also conclude
that a man, walking up a mountain,
whose arterial oxygen tension was
lowered, had "respiratory failure,"
which isn't strictly true. So you can
invent possible definitions only to discard them. I do not think there is
much interest in following that line of
thought.
I do think it is valuable to distinguish between acute and chronic respiratory failure. We can recognize
that there is a state of chronic maladjustment or inadequacy, with com-

* Presented as the second of the Seventeenth Annual Stoneburner Lectures at the
Medical College of Virginia, March 12,
1964.
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pensatory adjustments of polycythemia and bicarbonate retention. We can
recognize not only acute and chronic,
but acute on chronic; this category includes many of the patients with respiratory failure that we commonly
encounter. They have been precipitated into an acute dangerous situation, often having lived satisfactorily
for several years with a chronic form
of respiratory failure. In table 1 are
set out some of the common forms of
acute and chronic respiratory failure.

TABLE 1

Respiratory Failure

A. Chronic:
1. Chronic hypoventilation with
normal lungs :
a. Neuromuscular disorders .
b. Skeletal deformity.
c. Primary alveolar hypoventilation syndrome.
2. Chronic hypercapnia (pC0 2i)
and hypoxia (p02ll as consequence of chronic lung disease
(V / Q distribution abnormality). Arterial pH usually normal as a result of bicarbonate
retention.
B. Acute:
1. Acute infection superimposed
on chronic respiratory fai lure.
2. Acute respiratory depression .
3. Acute status asthmaticus .
4. Chest injury.
5. Acute paralysis.
6. Following cardiac arrest or
pulmonary edema.

Insidious Nature of Respiratory Failure

The first point I wish to stress is
that progressive hypoventilation is a
dangerous condition and very difficult

sometimes to spot clinically. Let us
consider a patient who has just been
operated on. He has an oxygen uptake of 300 ml per minute, a respiratory quotient of 0.8, which is average,
and an alveolar ventilation of 5 L per
minute. His arterial oxygen tension
will be 100 mm of Hg on air; his
saturation 96 %; the arterial C02 tension will be 40 mm of Hg; and the
pH 7.40. I want you to notice what
happens if you just depress his alveolar ventilation, by 1 L per minute,
in steps, keeping everything else the
same, and assuming that his lung has
perfect gas distribution and a normal
diffusing capacity. When I drop it 1 L
per minute, I have dropped the arterial oxygen tension to 82 mm of Hg.
The saturation is still high because of
the shape of the dissociation curve;
the pC02 has gone to 50 mm of Hg
and with no bicarbonate adjustment,
and the pH will have fallen to 7.32.
The next stage of a further liter per
mi nute drop in alveolar ventilation to
3 L per minute results in another fall
in arterial pO, . The saturation is now
87 % , which is not detectable as cyanosis, on air. The CO, tension will
now be about 75 mm of Hg. The patient, from perhaps being a little restless earlier if in pain, is noted by the
nursing staff now to be "sleeping
quietly." This is due to the anesthetic
property of C02 . The pH is now 7 .2
and the patient has reached a critical
situation; because if you drop alveolar
ventilation another liter per minute, it
is evident to everyone that disaster has
occurred. The oxygen saturation will
be 40 %, the arterial oxygen tension is
30 mm of Hg, and the C02 is up to
105 mm of Hg. It is this stage that is
critical in the postoperative period. In
other words, everything may be going
well until the patient, perhaps awaken·

ing with a lot of pain, is hit with a
moderate dose of Demerol. His ventilation is depressed and he now
sleeps quietly.
What happens next depends on a
number of circumstances, e.g., whether
he collapses a lobe of his Jung, which is
a very serious complication at this
stage, or whether he gets a slight degree
of pulmonary edema, which increases
the work of breathing and drops ventilation still further. Thus, the first important concept I want to present to
you is the insidious nature of respiratory failure. It is insidious particularly
in the postoperative situation. It is so
difficult to diagnose early in cases of
chest injury that you would be well advised to distrust your own or anyone
else's estimates of ventilation. In these
cases, a patient may come to the brink
of disaster with every observer convinced, until 20 minutes before, when
the blood pressure disappeared, that
there really hadn't been "too much of a
problem." It has been the great contribution of the last 15 years, with the
common availability of laboratory
methods, that we are getting a much
better idea really of what a dangerous
enemy respiratory failure may be.
And we also are beginning to understand the entity which was very commonly taught about 20 years ago,
namely peripheral circulatory failure.
The urgency of teaching about respiratory failure consists in recognizing that you can usually reverse it, at
least in part, and that by the time the
patient has moved into the next stage
of severe tissue hypoxia, or of circulatory failure, it may be too late.
Sieker and Hickam (Medicine 35:
389-423 , 1956), who I think introduced the term "C02 narcosis" for the
first time, made the point that, as severe respiratory acidosis is treated prop-

erly, and the C02 has fallen from 100
to 50 (or so) mm of Hg, the patient
may still be confused and drowsy. So,
just as in the treatment of diabetic coma
the return of consciousness does not
follow precisely the curve of the blood
sugar, the same is true in treating C02
narcosis. This occasionally can give rise
to anxiety. In one or two people we
have treated, we have been fairly convinced the patient must have suffered
irreversible cerebral damage, or possibly a cerebral thrombosis, because
we have had the pC02 at 40 or 50 for
1 hour or so and there has been little
return of consciousness; yet full recovery has occurred.
Circulatory
Failure

Changes

in

Respiratory

One of the important physiological
contributions to this area was the demonstration by Nahas and Cavert
(Am . J. Physiol. 190: 483-491, 1957)
that in the intact dog, giving C02 and
reducing the pH from normal levels
to 7 .1, caused a progressive fall in
cardiac output, which fell almost
linearly with the pH change. This was
mainly due to a fall in stroke volume.
Patterson (Proc. Roy. Soc. (London),
Ser. B 88: 371-396, 1915) had demonstrated as early as 1915 that CO,,
regardless of its pH effect, had a depressant effect on the isolated dog
heart. It has also been shown that the
body has a protection against this which
is the secretion of catecholamines,
which goes some way toward counteracting this effect. So my second point
is to emphasize that there is, almost at
the beginning, an inevitable interaction
between respiratory failure and the
state of the circulation.
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Superimposed Metabolic Acidosis

There is another very important
way in which these manifestations interact. When tissue perfusion is reduced below proper levels, even in the
presence of a normal arterial oxygen
tension, you get a brisk peripheral tissue hypoxia with accumulation of lactic acid. I think we really learned this
from early experiments of perfusing
dogs with cardiac bypass circuits in
which total cardiac output was inadequate, and watching the metabolic acidosis develop. The point was also
brought home strongly when we began
to restart hearts that had been stopped.
We found that after a few moments of
cardiac arrest the pH will be down at
6.9. Simply taking patients who have
high pC02 values or respiratory failure and plotting, to start with, the
plasma bicarbonate against the lactate, (and I do not have many observations here as this is work we have
in progress), the higher the lactate, the
lower the bicarbonate, which is to be
expected. And the lactic acidosis,
often reaching quite high levels in
these patients, is responsible for a
considerable part of the "total" acidosis. So this is the second interaction.
Failure of the circulation gives rise to
problems at the tissue level. When
these are severe enough to cause lactic
acidosis, you immediately add a metabolic acidosis to the respiratory one.
Table 2 summarizes these events sequentially.
Thus the physician's task is obviously 3-fold. The first problem is to
ensure oxygenation. The second is to
make sure that this is not causing
more hypercapnea. If the patient cannot get rid of CO, , his ventilation ·
must be assisted and the pC02 re44

TABLE 2

Sequence of Events in Acute Respiratory Failure

1. Acute elevation of pCO , .

l

2. Acute respiratory acidosis

(pH

low).

l
3. Secondary circulatory depression
with fall in cardiac output and
later cardiac arrest .

l
4. Secondary superimposed metabolic acidosis .

l
5. Final severe combined metabolic
and respiratory acidosis .

l
6. Cardiac arrest/ cerebral damage
and central respiratory failure.

l
Death

stored to near normal values. Third,
and only 1 or 2 minutes later, the
physician should worry about the
problem of acidosis-not only the respiratory acidosis but the possibility
of a quite severe metabolic acidosis.
If you face every problem of respiratory failure with these three thoughts
in your mind, and add a fourth, that
you should worry continuously about
cardiac output and renal blood flow as
these often will take the patient away
from you when you really deserved
success, you will realize that the treatment of respiratory failure is not an
isolated phenomenon; nor can it be
reduced solely to discussion of whether
to do a tracheostomy, or which particular tube to use, or what kind of
mechanical respirator to prefer.
The physician who treats respira-

tory and circulatory failure well is not
one man usually, but at least two and
sometimes three, who are accustomed
to think together when faced with
these problems, so that no aspect of
the total care is ignored. The best
management of such patients requires
a group of people accustomed to
working together without treading on
each other's toes, and accustomed to
thinking in terms of several systems in
the body at once. This is particularly
true after cardiac surgery, when the
management of some of these patients
certainly requires a team effort of the
kind I am sketching.
In table 3, I have summarized the
sequence of decisions the physician
may make in managing respiratory
failure.
I deliberately chose this topic not
only because it is something I am involved in and feel strongly about, but
because I wanted to concentrate on a
field in which I believe there have
been rather striking practical advances. The reasons for these are historically interesting. But, I do not
think anyone would deny or doubt
that the ready availability of arterial
blood gas analysis, which must be
available in an intensive care unit, at
least, 24 hours a day, has really played
a major part. I cannot imagine how
you can deal with many of these patients without knowing what you are
doing. The more centers there are
using routine blood gas analysis, the
more people have learned that there
really is no substitute for this particular kind of analysis in particular cases.
This whole field is at a stage when
many people are involved in it, some
willingly and some unwillingly. I
think we are all learning of the situa-

tions in which we do very well and
those in which, for some reason or
another, we do very poorly. I have
concentrated on it because I am quite
firmly convinced that this is properly
the province of the chest physician,
which I am. Although I have been on
occasion accused of being a pathologist, and described as a physiologist,
I am really a physician. If the modern
chest physician does not accept responsibility and take an interest, and
I would add, a devoted interest, in
this kind of management, he is going
to find that it is taken over by others.
Of course there are some people, anesthesiologists usually, who feel this
ought to be exclusively their province.
But I think, in the kind of patient I
have been showing you, that these are
often problems for the chest physician, who will certainly need help, and
assistance, and guidance from others.
We found it very useful in our intensive care unit to have the cardiac
group and ourselves side by side. Our
nurses are as competent to deal with
pacemaker-monitor
problems
and
coronary thrombosis patients as they
are with respirators. The chest physician must work very closely with cardiologists, certainly with surgeons,
and certainly with anesthesiologists.
But I would not welcome a situation in
which the essential problem of controlling breathing over long periods of
time, and of treating people in these
categories I have been showing you, is
turned over exclusively to people other
than the chest physician. With the decline of tuberculosis and the shift of interest to emphysema, the chest physician has to re-evaluate what he is doing.
And he has to make up his mind, I believe, to do at least two things: to be
able to apply simple physiological tests

of function to assist other physicians
and himself in the diagnosis and management of lung disease, and to become
an expert in managing respiratory
problems. The thought I leave with you
is that if he does not do both of these
things, he will find that his specialty has
disappeared.

TABLE 3

Sequence of Decisions in Management of Respiratory Failure

A. Accurate diagnosis: usually necessitating arterial blood gas
analysis, x-rays, ECG, etc.
B. Re-establish ventilation plus 0 2
administration.
C. Sequence of decisions on assisted
ventilation.
1. Simple assistance via mask plus
respirator, plus possibly stimulants. Use of 403 02 .
2. Endotracheal tube if
a. Prognosis probably hopeless .
b. Need of assistance probably
of short duration.
3. Cuffed tracheostomy tube
a. If secretions are a problem.
b. If long term assistance
(more than 4 days) likely.
c. If pC02 is higher than 75
mm for 3 hours or so in
spite of simpler measures .
4. Assisted ventilation plus muscle relaxants
a. In status asthmaticus .
b. In tetanus.
c. In lung injury.
D . Treatment of metabolic acidosis
(immediate if cardiac arrest has
occurred).
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The Interdependence of Pulmonary
Structure and Function: A Synopsis*
NORMAN C. STAUB

Cardiovascular Research Institute and Department of Physiology
University of California San Francisco Medical Center, San Francisco, California

It is a great pleasure to participate in
the 1964 Stoneburner lectures and to
present some recent views on the structure and function of the lung. In this
report I will give a brief summary and
show you three pictures to indicate
some of the inter-relationships that
exist. A more detailed review covering
similar material, with numerous color
illustrations, can be found in Anesthesiology 24: 831-854, 1963.
We all know that the venous blood
returning from the organs of the body
is pumped by the right ventricle
through the pulmonary artery into the
lung. It flows along the branching arterial system to the respiratory surfaces (alveolar-capillary level) where
it is aerated. The arterialized blood
drains via the pulmonary veins and
left atrium into the left ventricle,
which pumps it into the systemic circulation.
During inspiration, the air we
breathe flows down the trachea, into
the multibranching bronchi and bronchioles, and then into the respiratory
spaces (alveoli and alveolar ducts)
where oxygen molecules diffuse into
the red blood cells in the pulmonary
capillaries, and C02 molecules diffuse
out. During expiration, alveolar gas
flows back up the airways to the atmosphere.
One of the remarkable aspects of
pulmonary structure is the very close
relationship between the blood vessels

* Presented at the 1964 Stoneburner
Symposium.
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and the airways. Figure 1 is a picture
of the hilum of a lung lobe in an experimental animal, showing the main
lobar bronchus and adjoining it, the
pulmonary artery and the pulmonary
vein. These lungs were prepared by
rapid freezing in the open thorax in an
anesthetized animal. The colors you
see are not stains but are the actual
colors of the living lung. The photograph was made while the lung was
still frozen. Notice the dark venous
color in the pulmonary arterial blood
in contrast to the bright red color in
the pulmonary veins, and the snowwhite lining of the airways in contrast
to the orange color of the respiratory
spaces (alveolar walls) in the background. The main lobar bronchus
branches twice in the picture, and you
can see that each branch is accompanied by a pulmonary artery branch.
The pulmonary veins, on the other
hand, do not branch as evenly as the
arteries, nor do they follow the airways as closely.
The most important aspect of lung
function is the efficiency of getting
air and blood into close contact and in
proper proportion. We refer to this as
the balance of ventilation to perfusion.
It is the single most important feature
of lung function in health and in disease. Imbalances may be due to destruction or narrowing of airways, to
narrowing or occlusion of vessels, or
to destruction of the alveolar-capillary
walls within the respiratory portion of
the lung. Anatomically, we see how

closely the pulmonary artery (perfusion) follows the airway branchings
(ventilation). At each successive level
of the lung there is an intimate relation between the blood supply and
the air supply right down to the respiratory portion of the lung, the part
which I refer to as the terminal respiratory unit. When the blood and
air are within this unit, the diffusion
of oxygen and C02 gas molecules becomes the major process.
Figures 2 and 3 show two aspects of
the alveolar wall in human and in cat
lung. In contrast to figure 1, these specimens were fixed while frozen, then embedded, sectioned, and stained. The human samples were obtained at thoracic
surgery. These figures show the business portion of the lung (the alveolarcapillary wall). Here oxygen and CO.
molecules are exchanged between the
alveolar gas and the red blood cells in
the pulmonary capillaries. Note how
large the alveolar air space is relative
to the thickness of the alveolar wall
(fig. 2). Gas molecules move a great
deal faster through air than through
tissue (water). See how the blood cells
are spread out in a single layer and how
much of the alveolar surface area they
occupy (fig. 3).
By the insights afforded us when we
consider both organ structure and
function, we will be able to advance
our understanding of normal and abnormal conditions so that we may intelligently correct the latter.

Fig. 1-Cat, X 2.4. Left lower lobe, main
bronchus, and vessels at the hilum. This
is a frozen , uninjected, unstained specimen. It demonstrates clearly the purplish
color of partially desaturated (venous)
blood in the pulmonary artery and the
bright red color of well-oxygenated (arterial) blood in the pulmonary veins. The
plane of section is just after the lobar
bronchus enters the lung. The main bronchus is the large white opening. A small
lateral branch to the apical segment of
the lobe has been given off, and a large
anterior branch is forming. The main
bronchus continues nearly straight. Within
the bronchus there is a faint circular ridging due to the cartilage in the walls. The
pulmonary artery (PA) has divided, and
a branch accompanies each airway. PA
is one-third to one-half the diameter of
the adjacent airway at all levels down to
the terminal bronchiole. The pulmonary
vein is larger than the artery. It is in the
process of dividing. At the hilum the airway, pulmonary artery, and pulmonary
vein are close together because of space
limitations. This provides maximal mobility of the lung root. Note that even the
largest airways and vessels are surrounded
by alveolar tissue (orange background
color).

Fig. 2-Human, X 100. Fixed, 10-µ section, stained. Shows red blood cells in
alveolar capillaries confined to plane of
wall, not bulging into airspaces as so often
stated. About 50% of the alveolar septal
volume is capillary lumen. Endothelium,
interstitial connective tissue, and alveolar
epithelium make up the remainder. Septae
range from 5 to 10 µ in thickness in wellinflated lung. Human lungs were obtained
at thoracic surgery. The anesthetist inflated the lung fully, then allowed it to
deflate to a known airway pressure. The
surgeon then clamped the edge of a lobe.
At the time of clamping, pulmonary
blood flow was intact. The specimens
were frozen within 30 seconds of removal
from the chest.

Fig. 3-Cat, X 200. Fixed, thick section,
stained. Single alveolar wall in plane of
focus. Individual red blood cells in alveolar capillaries are clearly seen. Normally
the capillary net is not filled to capacity.
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Energy Requirements
of Breathing*

W. T. THOMPSON, JR.

Department of Medicine
Medical College of Virginia, Richmond

The mass movement of gases into
and out of the lungs is accomplished
by muscular work. This requires energy expenditure, caloric consumption, oxygen utilization, and carbon dioxide production. Inspiration is always
an active process, enlarging the volume of the thorax, thereby increasing
the negative pressure so that air flows
into the lungs. Expiration is ordinarily
passive but may require muscular
work.
The position of the chest wall at
rest is a mechanically neutral point
at which the tendency of the chest
wall to expand is balanced by the
tendency of the lungs to recoil. This is
the end expiratory level or midposition, and the lung volume at this point
is termed the functional residual capacity. An increase in chest size can
be achieved only by exerting pressure
greater than the elastic forces of the
lungs. In addition, airway resistance
to airflow and nonelastic tissue resistance must be overcome. In the
normal individual, 60 to 70% of the
total ventilatory work is required for
overcoming elastic forces, the remainder for overcoming nonelastic resistance, largely due to airflow.
Expiration is passive in the normal
individual during quiet breathing, the
energy stored in the elastic lung tissue
during inspiration being sufficient.
The diaphragm is the major muscle
of inspiration and is probably always
active even with so-called thoracic
breathing. It arises from the xiphoid
process, from the inner surface of the
last six ribs and their cartliages, and
from the lumbar vertebrae. By virtue
of its position and attachments, it not
only increases the vertical dimension
of the chest by a downward movement,
but also increases the transverse diameter by flaring the lower ribs.
The intercostal muscles are second
in importance to the diaphragm. The
external intercostal fibers run downward and forward and the internal
intercostal fibers are directed upward
and forward to the next rib, so that
contraction elevates the rib with resulting increase in the anteroposterior
diameter, transverse diameter, or both.
Studies by Koepke et al. (1958) showed
that the 1st intercostals are active in
quiet breathing of most individuals.
With increased ventilation, there is
increased utilization of the intercostals,
so that the majority of individuals use
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all intercostal muscles when ventilation
requirements approach 50 % of the predicted vital capacity.
The diaphragm and intercostals are
the only respiratory muscles used by
the normal individual under ordinary
circumstances. Other muscles are mobilized when ventilatory demands are
increased, either because of increase
in total ventilation in the normal individual or because of altered physiology
of respiration in disease states. The socalled accessory muscles of respiration
include particularly the scalenes, the
sternomastoid, and the trapezius.
The scalene muscles arise from the
transverse processes of the cervical
vertebrae and insert in the 1st and
2nd ribs. They serve to stabilize and
elevate the 1st and 2nd ribs. They are
not ordinarily employed in quiet respiration.
Although a well trained subject
was able to breathe 60 L per minute
without electromyographic evidence of
scalene activity, these muscles are ordinarily brought into play when an intrathoracic pressure of -5 to -6 cm of
H20 is exerted and chest volume is
increased by 800 to 900 ml of air.
On rapid inspiration they are brought
into action at the very beginning of
inspiration (Thompson, Patterson, and
Shapiro, 1964).
While many muscles of the thorax
may be used in severe dyspnea, only
the sternomastoid and the trapezius
will be considered. The former arises
from the manubrium and the sternal
end of the clavicle and inserts at the
mastoid process and lateral half of the
nuchal line. It can assist in lifting the
thorax. Campbell (1955) showed that
there was never any detectable activity
of this muscle in any subject during
quiet respiration, but that increasing
intensity of contraction was exhibited
as intrathoracic pressures progressed
from -10 to -50 cm of H ,O.
The trapezius arises from the occiput, the ligamentum nuchae, and the
spines of the last cervical and thoracic
vertebrae. It inserts into the acromial
3rd of the clavicle, and the scapula.
The upper fibers tend to lift the chest.
These muscles do not function with
equal effectiveness as muscles of respiration, and they are described in
order of decreasing efficiency. The diaphragm and the intercostals are peculiarly suited for their task of increasing the chest volume. The scalene
muscles have a direct pull to lift the
1st rib. The sternomastoid and trape-

zius are large muscles that have a poor
mechanical advantage in lifting the
thorax.
The normal individual at rest has
an oxygen requirement of about 300
ml that must be furnished, and produces about 240 ml of carbon dioxide
that must be eliminated. This is
achieved by a minute volume of approximately 7 L. About 2 % of the
total oxygen consumption at rest, or
some 6 ml, is used by the respiratory
muscles.
An individual with normal heart and
lungs is able to increase his ventilation considerably without much increase in total oxygen consumption.
As respiratory effort increases, the
oxygen cost of breathing becomes excessive in everyone, whether sick or
well. Eventually the point is reached
where the respiratory muscles consume so much oxygen that further increase in ventilation does not supply
additional oxygen for utilization by
other tissues of the body. With this
there is a greatly increased production
of carbon dioxide, and carbon dioxide
retention may occur because alveolar
ventilation cannot keep pace with the
carbon dioxide produced by the respiratory muscles. This point is estimated to take place in the normal subject at ventilatory levels of about 140
L per minute.
In patients with lung disease, the
ventilatory work is often increased, so
that there may be a disproportionate
oxygen utilization and carbon dioxide
production by respiratory muscles even
at rest. This is particularly apt to occur in patients with airway obstruction,
especially in those with chronic obstructive pulmonary emphysema. The
effective ventilatory level may be
reached at 15 to 20 L per minute in
such patients. Any efforts to increase
ventilation further only add oxygen
which is used by the respiratory muscles. Carbon dioxide is produced in
excess of the ability to excrete it,
and respiratory acidosis may be worsened.
The energy problems of patients
with lung disease, particularly those
with emphysema, are multiple. They
often must use the less efficient accessory muscles at rest, a breathing
pattern the normal subject uses only on
extreme exertion. The mechanical efficiency of these muscles is poor, their
oxygen consumption and carbon dioxide production being out of proportion

to their contribution to effective alveolar ventilation.
The diaphragm is a much less
effective inspiratory muscle when it
is flattened by overdistended lungs. Its
contraction no longer increases the
vertical dimension of the chest. Furthermore, it acts like a flat sheet of
muscle, draws the lower ribs together,
and thus reduces rather than increases
the transverse diameter.
Expiration which is normally passive may require muscle activity. This
is because of loss of elastic recoil of
lung and because of obstruction to
expiratory airflow. Unanswered is the
question of whether there is structural
or biochemical change in the respiratory muscles so that they require more
oxygen and do less work.
Many patients with chronic lung
disease are alive only because their
respiratory muscles are able to perform increased work day in and day
out. Greater force must be exerted if
effective alveolar ventilation is to be
maintained and blood gases kept at
tolerable limits. This means that caloric intake must be adequate, nutrition must be good, and muscle tone
and strength must be maintained. The
nutritional care, particularly of patients with chronic pulmonary emphysema, has in the past received little
attention. There is a tendency for attention to be centered on the more
obvious pulmonary abnormalities and
to disregard measures designed to improve and maintain the nutritional

status of the patient. In the past we
have repeatedly observed such patients
to exhibit rapid and progressive loss
of weight with concomitant deterioration in their condition. Two factors
appeared to be responsible primarily
for the loss of weight in these patients:
(1) loss of appetite, which seems, at
least in part, to be related to infection and to gastric distention, and (2)
patients with advanced pulmonary insufficiency frequently develop severe
dyspnea while eating. The distress resulting from shortness of breath thus
limits the time that these patients are
willing to spend in chewing and swallowing their food. As a result they
take smaller meals and their caloric
intake may be severely compromised.
This chain of events and the interaction of the different factors described
above are graphically represented in
figure l.
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Relative Incidence of Pulmonary
Emphysema among Negroes
and Whites of Both Sexes*
EDWARD S. RAY

Department of Medicine, Medical College of Virginia, Richmond

A striking clinical feature of emphysema is its predominance among
white males, and its relative infrequency among Negro females. This is
true, at least in the state of Virginia,
as shown by recent figures of death
rates from the disease (table 1).
To further evaluate the incidence of
this disease, the records of patients at
the Medical College of Virginia were
reviewed. Included in this study were
hospital and clinic admissions for the
years 1961 and 1962, and private outpatients seen during the years 1960,
1961, and 1962. The MCV hospitals
admit approximately 35,000 patients
yearly with a ratio of 51 % white and
49% Negro. The out-patient clinics
admit about 90,000 patients annually
with a ratio of 28% white and 72%
Negro.
The criteria for making a diagnosis
of emphysema were: shortness of
breath as a major complaint, generalized suppression of breath sounds and
expiratory wheezing, a I-second forced
expiratory volume of less than 70% of
the total vital capacity, and x-ray evi-
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dence of limited motion and depression of the diaphragms. Only patients
fulfilling these criteria, but showing no
evidence of other lung diseases, were
included in this study (370).
Smoking Habits

The great majority of the patients
(315) gave a history of cigarette smoking (table 2). The sex and race distribution of these figures (table 3) almost
parallels that of death rates from the
disease. The data on smoking habits
of these patients could not be evaluated accurately as the habit varied in
individuals from year to year, and
some patients had difficulty in recalling accurately their precise smoking
habits over the years. Some individuals
tended to underestimate the number
of years they had been smoking, and
some had reduced their smoking in
recent years because of progressive
respiratory symptoms. Of the 315 patients with emphysema, most had
smoked for 30 years or longer (table
4). A great majority of these patients
smoked a package or more of cigarettes daily (table 5). Thus there appears to be a correlation between the
degree and duration of cigarette smoking and the incidence of significant
pulmonary emphysema.

Cigarette Smoking among
Hospital and Clinic Patients

General

Because of the marked differences
in the incidence of emphysema according to sex and race, differences in
the smoking habits of these groups
were examined. A survey was made of
the smoking habits of patients on the
general hospital wards and in the OutPatient Clinic. Only patients who were
40 years of age or older were included, as a pattern of smoking is not
usually developed before this age. A
total of 600 individuals were interviewed, 150 of each sex and race
(table 6). There was a significant difference in the smoking habits of the
two sexes and a smaller difference between the two races; white males being the heaviest smokers, followed by
Negro males and white females (p
<0.01 for each combination); Negro
females smoked the least. These differences in smoking habits correspond to
the difference in frequency of emphysema between the two sexes, but do not
explain the greater difference in incidence between white and Negro males.
Possibly the population selection was
biased, as only clinic and hospital patients were interviewed. Possibly also
other factors, such as occupation or
host reaction, are important.

TABLE 1

TABLE 5

Deaths from Emphysema in Virginia According to Sex and Race*

Sex and Race

1959

1960

1961

Male, white . .. . ··· ·· ·· . . .
Male, Negro . . .. ········ .
Female, white. . . ... . .. . ..
Female, Negro. . . .. .. . ..

106
14
JO
I

148
19

188
21
30
1

22
I

Intensity of Smoking among 315
Patients with Emphysema

1962
230
25
48
5

(753)
(73)
(163)
(23)

Daily Consumption of
Cigarettes

No.

Percentage
of Total

10
10-20
20-30
30

0
6
181
128

0
2
57
41

* Data of the State Bureau of Vital Statistics.

TABLE 2

TABLE 6

Smoking History o f 370 Patients

Smo king Habits in Fo ur Patient Samples (150 each) from the G eneral Hospital
a nd Clinic Population, Separated b y Sex and Race

with Pulmonary Emphysema

PercentNo. age
of
Total

Smoking Habits

Cigarette smokers . . .
315
Pipe and cigar smokers . .
5
Smoking not recorded . . . 42
Nonsmokers.
8

85
12
2

Daily Cigarette
Consumption

Ot
1-20
> 20

Pipe
Cigar

No. of Patients*
Male, white
17
22
106
1
4

Male, Negro

(11)
(15)
(71 )
(0)
(3 )

16
52
66
8
8

Female, white

(JO )
(36)
(44 )
(5)
(5)

73
32
43
2
0

(50)
(20 )
(30)
(0 )
(0 )

Female, Negro
93
36
21
0
0

(62 )
(24 )
(14)
(0 )
(0)

* Numbers in parentheses indicate the percentage of total in each group.
among females than among males (p < 0.01) regardless of race, but no significant difference between the two races in either sex.

t Significantly more nonsmokers

TABLE 3

Sex a nd Ra ce Distribution among
315 Patients with Emphysema Who
were Smokers

Sex and Race

No.

Percentage of
Total

- - - -- - - -- - - - - -Male, white. . . . . . . . .
Male, Negro . .. . .. . . .
Female, white. . . . . . .
Female, Negro. . . . .

251
25
36

80

8
11
1

3

TABLE 4

Dura tion of Cigarette Smoking in
3 15 Patients with Emphysema

Years of
Smoking

No.

Percentage
of Total

< 10
10-20
20-30
30-40
>40

0
2
36
110
167

0
1
11
35
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A factor influencing cigarette smoking among females is that they are
more likely to become concerned
about cough and expectoration than
are men, and are therefore more likely
to seek medical attention. In my own
experience, men often tolerate a moderate amount of cough and expectoration for years without complaining
and without seeking medical advice.
This is especially true of men who are
cigarette smokers who assume (and
rightly) that such symptoms are related to their smoking. Women, on the
other hand, try to avoid cough and
expectoration and are more likely to
smoke less to reduce these symptoms.
This could explain, in part, the difference in the smoking habits between
the two sexes. However, a sampling of
a small number of females of both
races under 40 years of age showed
that cigarette smoking is commoner in
this age group than in older women.
One may expect, therefore, an increase in frequency of emphysema
among females of both races during
the next decade or two.

Summa ry

1. There is an apparent correlation
between cigarette smoking and the incidence of pulmonary emphysema. An
increased incidence of emphysema is
associated with increased cigarette
consumption. The disease is relatively
infrequent in those who have smoked
less than a pack of cigarettes daily for
less than 20 years.
2. The low incidence of emphysema
among females today may be explained by their low cigarette consumption. If this is true, this incidence
should increase within the next decade because of cigarette consumption
among today's younger females.
3. The incidence of emphysema is
lower among Negro males than would
be expected from their smoking habits
alone.
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Pulmonary Surfactant
and its Relation to Disease*

SAMI I. SAIDt

Department of Medicine, Medical College of Virginia, Richmond

Perhaps the most important advance
in respiratory physiology during the
past decade is the discovery of the
role of surface phenomena. This has
been in large measure the result of
pioneer work by Pattie, in England,
and Clements, in the United States.
The following is a simplified and
brief review of present knowledge of
surface tension, as it relates to normal
and abnormal pulmonary function.
(For further reading on the subject
pelase refer to these recent reviews:
Clements, 1962a and 1962b, Pattie,
1958, 1961 , and 1965, and Mead,
1960.)
First, what is surface tension? When
a liquid is in contact with the air, the
molecules at the surface of the liquid
will be under tension (fig. 1). This is
because, while the molecules away
from the surface are attracted equally
by other molecules from all directions,
those at the surface are influenced only
by molecules below and to the side, but
none above. The net effect is that the
surface molecules tend to be pulled
down, and therefore, the surface tends
to get smaller.
And because surface tension is a
force acting in the same plane as the
surface, e.g., like the pull on the cord
of a window curtain, it has units of
force per length, e.g., gm per cm or
dynes per cm, whereas pressure has the
units of force per area, e.g., gm per
cm2 or pounds per square inch.
Now, what could this have to do
with what goes on in the lungs? We
will begin to appreciate the link when
we consider the case of a gas-liquid
interface that has a spherical shape,
like that of an alveolus. A soap bubble
is a good example. Here, the tendency
of surface tension to shrink the surface
will ultimately result in collapse of the
bubble. And it can be shown that the
total forces tending to empty the bubble
will amount to twice the tension in the
wall divided by the radius of curvature.
This relationship is known as the law
of Laplace, and it appears to hold for
alveoli just as well as it holds for soap
bubbles. It means simply that for a
sphere, the surface forces will increase
if the tension in the wall increases or
if the radius of curvature decreases. It

* Presented at the 1964 Stoneburner
Symposium.
t Recipient of U. S. Public Health
Service Career Development A ward HEK3-18,432 from the National Heart Institute.
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Fig. I-Molecules at a gas-liquid interfa ce are under tension (after Mead, 1960).

Fig. 2-A system of bubbles in parallel is unstable; smaller bubbles have
greater surface forces (P) and therefore
tend to collapse first (after Mead, 1960).

Fig. 3-Pulmonary alveoli are inherently
unstable, but a surface-active lining (surfactant) lowers alveolar surface tension
and thus protects them against atelectasis.
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Fig. 4-Schema of fluid exchange in
lung.

also means that, for the surface forces
to remain balanced, a decrease in radius of curvature must be counteracted
by a decrease in tension. A beautifully
clear presentation of these relations was
given by Mead (1960).
To get a step closer to the lung, we
now examine what happens when two
soap bubbles are blown at the end of
a Y-tube and are arranged, so to
speak, in parallel-like two alveoli
with a common airway (fig. 2). If one
bubble happens to be smaller than the
other, we might expect that air would
leave the larger bubble to enter the
smaller bubble, until the two became
equal in size. But this is not what happens. According to the law of Laplace,
the smaller bubble must have a higher
surface force (P), since its radius of
curvature is smaller. In other words,
the forces tending to collapse the
smaller bubble are greater than those
trying to empty the larger bubble. As
a result, the smaller bubble empties itself into the larger one.
Turning now to the lung, we find
that we have hundreds of millions of
alveoli, offering a large area of contact
between blood and gas (of the order of
70 M 2 ) , sufficient to permit the exchange of oxygen and carbon dioxide.
At the same time, we find that the
alveoli also present, on their inner surface, a large area of contact between
air and tissue fluid. This means that
the forces of surface tension are bound
to come into play. And since the alveoli are not all equal in size, and since
all of them get smaller during expiration, then, just as the smaller soap
bubble emptied into the larger one, the
smaller alveoli would tend to collapse
into the larger ones, until we were left
with a single large air space. That, of
course, would be disastrous, for the
processes of gas exchange would no
longer be possible.
Fortunately, however, this does not
happen, because the lung is endowed
with a special detergent, or surfaceactive material, which is capable of
reducing surface tension and adjusting
it when necessary. This is surfactant
(fig. 3). Pulmonary surfactant, therefore, stabilizes the alveoli and protects them against an inherent tendency
for collapse or atelectasis. It does so
by decreasing surface tension in
smaller alveoli, thereby balancing out
the effect of their smallness and, con-

sequently, maintaining uniform surface
forces throughout the lung and
throughout the respiratory cycle.
Another important function of pulmonary surfactant is explained in figure 4. Normally, a delicate balance of
fluid exchange exists between alveoli
on the one hand, and capillaries on
the other; only a thin fluid film lines
the alveoli. The forces of hydrostatic
pressure, alveolar fluid osmotic pressure, and surface tension, all tend to
drive fluid out of the capillaries and
into the alveoli. In the absence of surfactant, these forces would be opposed
only by the plasma colloid osmotic
pressure, and fluid and blood tend to
leak into the alveolar spaces. Pulmonary surfactant, therefore, protects the
alveoli not only against atelectasis, but
also against pulmonary edema and
hemorrhage.
Consequently, we would expect lack
of surfactant to result in three major
pathologic changes in the lung; atelectasis, edema and hemorrhage-perhaps
in varying degrees of predominance.
This is indeed what happens when the
surfactant is missing or ineffective
(fig. 5).
At present, the available methods
for evaluating lung surface tension
properties are indirect and not quantitative. A sample of lung tissue (1 to 3
gm) is minced and extracted in saline.
The extract is then filtered and poured
onto the trough of a surface balance
(Wilhelmy type) that permits automatic compression and re-expansion of
the surface area and the simultaneous
recording of surface tension (fig. 6) .
The latter measurement depends on the
pull exerted on a thin platinum strip
by the superficial layer of the fluid,
which should contain any surface-active substances that may be present in
the lung. The ability to reach low surface tensions (below 10 dynes per cm),
and a wide variation of tension with
changes in surface area, are characteristic of normal lung extracts. Lungs
with abnormal surface properties give
extracts that fail to reach a low surface
tension even on maximal compression.
How is pulmonary surfactant normally formed? What is its chemical
nature? And why is it deficient in
some conditions of disease or experiment? The answers to these questions
are only partially known. There is evidence that certain granular alveolar
cells are responsible for manufacturing
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this special surface-active material lining the alveoli. With the electron microscope, it has been suggested that
mitochondrial activity in these cells,
manifested as transformation into
lamellar forms, is closely related to the
formation of surfactant.
As for its chemical composition,
pulmonary surfactant appears to be a
complex of lipids and protein, the chief

component responsible for surface activity being dipalmityl lecithin, a phospholipid. (Lecithin is commonly used
commercially for its emulsifying properties, e.g., in candy and cookies.) The
protein appears to be an a-globulin.
Adult mammalian lung can actively incorporate circulating fatty acids into
phospholipid and can also synthesize
its own fatty acids.

Alveolar surfactant has been found
missing or lacking in a number of
clinical and experimental situations
(table 1). The finding of abnormal surface activity of lung extracts from infants dying of hyaline membrane disease (respiratory distress syndrome)
was the first time surface tension was
linked to a disease entity. Thanks to
Avery and Mead (1959), this discovery

TABLE 1

Clinical and Experimental Conditions
That May Be Associated with Insufficient or Ineffective Surfactant

1. Immaturity
2. Hyaline membrane disease
3. Pulmonary artery occlusion
4. Pulmonary
edema

5. Cardiopulmonary bypass
6. Vagotomy (in
some species)
7. O, poisoning
8. Severe respiratory acidosis

TABLE 2

Present Knowledge of Pulmonary
Surfactant
1. A surface-active material (surfact-

Fig. 5-Lung of dog showing edema, hemorrhage, and microscopically, areas of atelectasis. Surface tension of saline extract of this lung was abnormall y high.

Fig. 6-Photograph of balance for measuring surface tension of lung extracts (manufactured by Kenneth Wilson, 508 W. Joppa Road, Towson, Md.
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ant) lines the pulmonary alveoli of
adult mammals.
2. It is probably a lipoprotein (phospholipid +globulin) .
3. It is probably synthesized in the
lung , by alveolar cells.
4. Impaired synthesis , excessive de pletion, or inhibition of surfactant
leads to alveolar instability : atelectasis , hemorrhage, and edema .

put the subject in a totally different
light; from one largely of theoretical
interest to a practical and tangible
problem. Abnormal extract activity is
also found in several conditions that
are associated with impairment of pulmonary blood flow: occlusion of a
pulmonary artery, following cardiopulmonary bypass through a pump oxygenator, and as a result of induced pulmonary edema. Pulmonary surface
tension properties are also probably
impaired following vagotomy in some
small animals, in the rather unusual
experimental preparation where an animal is made to breathe while immersed

under fluid-thus using its lungs as
gills, and in oxygen toxicity, due to
prolonged breathing of pure oxygen,
particularly under increased pressure.
T his latter condition has received considerable attention because of its importance to astronauts and other space
travelers and in therapy with hyperbaric oxygenation. The list of conditions in which surfactant may be altered
gets longer as more work is being done
on the subject.
The manner in which pulmonary
surface activity is altered in these conditions is not clear. In some cases there
is probably impaired synthesis of surfactant, in others, a circulating inhibitor, and in others yet there may be too
rapid dissipation. In any event, the importance of surface tension in pulmonary disease is now fully recognized,
and future work will no doubt provide
more answers.
To summarize (table 2), alveoli of
mammalian lungs are normally lined by
a surface-active material or surfactant,
composed chiefly of phospholipids and
protein. Surfactant is normally synthesized in the lung. Formation depends, among other things, on normal
pulmonary blood flow, intact vagus,
and the activity of certain alveolar cells
that have reached an adequate level of
maturity. Its absence leads to alveolar
instability: atelectasis, pulmonary hemorrhage, and edema.

"The diver is generally safe
enough on the bottom, but when
he comes up care is needed. His
danger is from bubbles which may
form in his blood or tissues when
the pressure is taken off, just as
they form in a bottle of lemonade
or soda water. There is a story
that when one of the first tubes
was being driven under the
Thames, the directors of the company celebrated its arrival under
the middle of the river by having
lunch in the tunnel. They went
into an air lock, the steel door
was shut behind them, and the
pressure raised till it reached that
in the end section of the tunnel.
Then a door at the other end was
opened, and they went on to lunch.
As we know, company directors
always have champagne for lunch,
and these were no exception to
the rule. But when the bottles were
opened the champagne did not
fizz. The pressure outside the bottles was as big as that inside them.
However, the directors drank the
wine. After lunch they went back
to the lock, and the pressure was
lowered. They soon began to feel
very uncomfortable. As the pressure fell the wine began to fizz, and
the financiers to suffer from inflation!"

J. B. S. Haldane, Adventures of a Biologist. New
York: Harper and Brothers
Publishers, 1940, pp. 80-81.
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Curiosities of Medicine. An Assembly
of Medical Diversions. 1552-1962.
Berton Roueche, ed. New York: Berkeley Publishing Corporation, 1964.
254 pp. $.60.
The welcome appearance in paperback form of the 1963 Little, Brown
and Company edition should guarantee
a wide audience for this collection of
medical curiosa. The 21 selections,
with introductory notes by the editor,
range from a description of the sixteenth century's mysterious "Sweating
Sickness" by John Caius to the 1962
JAMA paper on "Glue Sniffing in
Children" by Glaser and Massengale.
In between, the epidemiological classics of Panum (measles, 1847), Snow
(cholera, 1854), Budd (typhoid, 1873),
and Pickles (pleurodynia, 1939) vie
with Matthew Carey's work on the
1793 Philadelphia yellow fever outbreak and William Beaumont's Experiments and Observations on the Gastric
Juice and the Physiology of Digestion
(1833).
Two papers from the 1961 Journal
of the American Medical Association
and the New England Journal of Medicine deal with "Stomach Cancer in
Iceland" and "The Case of the Perilous Prune Pit," a refreshing autobiographical note on the small bowel
meanderings of a fruit's inner core.
Samuel Hopkins Adams, a layman who
had the unique honor of becoming an
associate member of the AMA, discusses the vagaries of Latrodectus
mactans-the black widow spiderand Ashley Montagu, an anthropologist, reviews the peculiar mammalian
habit of yawning. Cardiology and psychiatry each have two papers to their
credit while an extract from Dubos'
The White Plague (1952) shows how
consumption was regarded during the
Romantic Era of the 19th century. Readers interested in philosophy
should like Dale's article presenting
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the medical biography of Immanuel
Kant.
Mr. Roueche, whose Eleven Blue
M en1 has received popular acclaim, is
author of the New Yorker's "Annals
of Medicine." He received a 1961 Albert Lasker Award for his work-an
indication of the clarity and accuracy
of his writing. In his Curiosities of
Medicine, Mr. Roueche has produced
not only a most readable and enjoyable
volume but also a work of scientific
merit from both the historical and contemporary viewpoints.
FrederickJ.Spencer,M.B.,B.S.,M.P.H.
Professor and Chairman
Department of Preventive Medicine
Medical College of Virginia
1 Roueche, Berton. Eleven Blue Men.
New York: Berkeley Publishing Corporation, 1955. 189 pp. $.60.

Body Fluids and the Acid-Base Balance. Halvor N. Christensen. Philadelphia: W. B. Saunders, 1964. 506 pp.
$6.50.
The rapid growth of scientific information has made it increasingly
difficult for many teaching institutions
to do justice to a subject matter in
the lecture hall and the student laboratory. As a result, there has to be a
certain amount of selection of topics,
and at times, some degree of superficiality. More and more study "in
depth" must be done by the student in
the form of "homework." The conventional way of doing this is by making a thorough study of voluminous
textbooks and monographs. Another
method is by the use of a self study
program. As the student proceeds in
his studies, he is required to answer
questions and solve problems. As a reward for having given the correct
answers, he may continue with the program.
Body Fluids and the Acid-Base Bal-

ance, by Halvor N. Christensen, is
such a program of self study written
for students of the biological and medical sciences. As any preclinical and
clinical lecturer can testify, students
at all levels of training all too often
encounter difficulties in comprehending biological acid-base problems. In
the view of Dr. Christensen, this may
result from the "presence of unexpected deficiencies, often minor, over
which the student nevertheless cannot
easily leap." This self study program,
hopefully, may correct the situation.
This volume of 506 pages with 1,100
"items," i.e., problems, simple and
more difficult ones, covers all the material that any accredited medical
school offers its students in this area:
pH and Dissociation, Sodium and
Chloride Distribution, Potassium and
the Cellular Compartment, Calcium
and Phosphorus, Gas Transport, Metabolic and Respiratory Aspects of Neutrality Regulation, and Renal Correction of the Neutrality. Written by a
very competent biochemist (Christensen is professor and chairman of the
department of biochemistry at the
U niversity of Michigan), the emphasis
of the book is on understanding fluid
and acid-base balance in the normal
subject. No other subject matter cuts
more deeply into all the biological and
medical specialties than fluid balance
and acid-base regulation. Since this
self study program already has stood
the test prior to its publication, it is
hoped that preclinical and clinical
teachers will familiarize themselves
with this book and recommend it
strongly to their students.

V. Christie. Philadelphia: W. B. Saunders Company, 1964, 566 pp. $15.50.
Doctors Bates and Christie have
written a much needed book. Their
text, directed chiefly to the internist and
the chest physician, is an up-to-date
and comprehensive review of respiratory function alterations in disease,
correlated with clinical , x-ray, and
pathological findings.
The book opens with a brief analysis
of methods for evaluation of different
aspects of pulmonary function, and a
summary of present knowledge of normal structure and function, including a
discussion of variations due to posture,
age, exercise, and altitude. Then follow several particularly strong chapters
on airway diseases (spasmodic asthma,
chronic bronchitis, and emphysema),
and others on pulmonary cysts, bronchiectasis, atelectasis, diffuse interstitial
fibrosis, sarcoidosis, acute infections,
and tuberculosis. Separate treatment
is also given to pulmonary function in
diseases of the chest cage, in heart,
collagen diseases, malignancies, and a
few other less common entities. The
last chapters are devoted to considerations of physiological principles in the
management of respiratory failure, and
in the evaluation of dyspnea and disability.
The book reads easily, is well indexed by author and subject, and has a
wealth of references on practically
every topic. My own feeling is that
with a Comroe1 under one arm and a
Bates and Christie under the other,
teachers and practitioners of chest
medicine should be extremely well prepared for their tasks.

Ernst G. Huf, Ph.D., M.D.
Professor of Physiology
Medical College of Virginia

Sarni I. Said, M.D .

Respiratory Function in Disease. An
Introduction to the Integrated Study of
the Lung. David V. Bates and Ronald

'Comroe, J. H., Jr., R. E. Forster, II,
A. B. Dubois, W. A. Briscoe, and E. Carlsen. The Lung. Clinical Physiology and
Pulmonary Function Tests (2nd ed.). Chicago: Year Book Medical Publishers,
1962.
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Germany. He came to the Medical College of Virginia in 1957 with appointments in the departments of ophthalmology and biophysics.

Ebbe Curtis Hoff (Gastric Secretion
Mediated by Extravagal Neural Infiuences) is chairman of the division of
psychiatric research in the department
of psychiatry and dean of the Medical
College of Virginia School of Graduate Studies. He received a B.S. degree
from the University of Washington in
Seattle, and an M.A., Ph.D., and M.D.
from the University of Oxford, England. Before coming to Richmond, Dr.
Hoff was on the faculty of Yale University School of Medicine. During
World War II he was a Commander
(Flight Surgeon) in the United States
Naval Reserve.
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Guy Wong (The Effect of ldoxuridine (!DU) on Corneal Stromal Cells
in Tissue Culture) has been at the
Medical College of Virginia since 1963
as NIH trainee in the department of
ophthalmology. He was born in Dunsmuir, Calif., and received his medical
education at the University of Washington School of Medicine.

David V. Bates took his M.B.,
B.Ch., and M.D. degrees at Cambridge
University and later was research fellow with Dr. Julius H. Comroe, Jr.,
in the department of physiology and
pharmacology, Graduate School of
Medicine, University of Pennsylvania.
After serving as senior lecturer at the
University of London, he went to
McGill University, Montreal, where
he is now associate dean, professor of
experimental medicine, and director
of the Cardiorespiratory Service at the
Royal Victoria Hospital. In March,
1964, he came to Richmond to give
the Seventeenth Annual Stoneburner
Lectures.

William Taliaferro Thompson, Jr.
(Energy Requirements of Breathing)
was chief of the Medical Service at
McGuire Veterans Administration
Hospital until he came to MCV as
professor and chairman of the department of medicine. He was graduated
from Davidson College and the Medical College of Virginia. He entered the
Army and was a staff member of the
45th General Hospital overseas with
Dr. L. T . Stoneburner, III, for whom
the annual lecture series has been
named. Dr. Thompson was born in
Petersburg, Va.

Norman C. Staub (The Interdependence of Pulmonary Structure and
Function: A Synopsis) is a native of
Syracuse, N.Y. He is a staff member
of the Cardiovascular Research Institute, University of California Medical
Center, San Francisco, under the directorship of Dr. Julius H . Comroe, Jr.
He is also associate professor of physiology at the University of California
Medical School in San Francisco. He
received his M .D. at the State University of New York at Syracuse.

Edward S. Ray (Relative Incidence
of Pulmonary Emphysema among Negroes and Whites of Both Sexes} is associate professor and chief of the pulmonary section in the department of
medicine, Medical College of Virginia.
He received his medical education at
the University of Virginia and took his
postgraduate training at Western Reserve Hospitals, Cleveland Tuberculosis Hospital, and the Medical College
of Virginia.

Sarni I. Said (Pulmonary Surfactant
and Its Relation to Disease), editor of
the Quarterly, is associate professor of
medicine at the Medical College of
Virginia, where he has taught since
1958. Dr. Said was born in Cairo,
Egypt, where he received his medical
degree in 1950. His training in internal
medicine was partly in Cairo and partly
at Bellevue Hospital and New York
University. After a research fellowship
with Dr. Richard L. Riley at the Johns
Hopkins Hospital, he joined the department of medicine at the Medical
College of Virginia.

Photographs by Willia m Notman , Montreal (Dr.
Ba tes); Myron Tooley, Richmond (Dr. Ray); James
Anderson, Richmond (Dr. Turner) ; and Wirt Christian (all others).
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Calendar of Postgraduate Education
MEDICAL COLLEGE OF vmGINIA/ SPRING 1965

APRIL 21-24, 1965

POSTGRADUATE COURSE IN PEDIATRIC RADIOLOGY WITH EMPHASIS ON TOPICS OF PRACTICAL IMPORTANCE
A three-and-one-half day course designed especially for
the clinical radiologist, pediatric radiologist, and pediatrician, but open to all interested physicians. The course
will be presented by members of the faculty of the Medical
College of Virginia and guest faculty.
TUESDAY-APRIL 20

P.M.
4-8

Registration, Hotel John Marshall.

WEDNESDAY-APRIL 21

A.M.

THURSDAY-APRIL 22

A.M.
8: 30-9 : 15
9 : 15- 10
10-10 : 30

Pediatric Urological Problems-Clinical
A spects-Dr. Platou.
Urologic Problems in Infants and Children
-Roentgen Aspects-Dr. Singleton.

Intermission

10: 30-11 : 15 Retro peritoneal Masses in Infants and Children-Dr. J. A. Kirkpatrick, radiologist, St.
Christopher's Hospital for Children and
Children's Heart Hospital; associate professor of radiology, (pediatrics) Temple
University School of Medicine.
11 : 15-11 : 45 Radiotherapy for Tumors of the Genitourinary Tract- Dr. E. R. King, professor and
chairman, division of radiation therapy, department of radiology, MCV.

8-8: 30

Registration, Hotel John Marshall.

P.M.

8 :30-8 :40

W elcome-Dr. R. Blackwell Smith, President, MCV.

8 :40-8:45

Introduction-Dr. Richard G. Lester, chairman, department of radiology, MCV.

11 :45-12:30 Voiding Cystourethrography-Dr. E . Van
Epps, professor and chairman, department
of radiology, State University of Iowa College of Medicine.

8 :45-9 : 30

Radiation Hazards in Diagnostic Radiology
-Dr. F. T. O'Foghludha, associate professor, division of radiation physics, department of radiology, MCV.

12:30-1:30

Lunch

1: 30-2: 15

Diagnostic Approach to Infants with a
Large Head-Dr. Kirkpatrick.

2: 15-3

Neuroradiological A spects of Epilepsy-Dr.
M. P. Neal, associate professor, division of
radiodiagnosis, department of radiology,
MCV.

3-3: 15
3: 15-4
4-5
6:30-7:30

Intermission
Cervical Spine in Infancy and ChildhoodDr. Van Epps.
Film session
Social hour

7 :30

Dinner

9 : 30-10 : 15

Pneumonias in the Pediatric A ge GroupDr. R. V. Platou, professor and chairman,
department of pediatrics, Tulane University School of Medicine.

10 : 15-10: 45

Intermission

10 : 45-11 : 30

Pneumonias of Early Infancy with Emphasis on Roentgenologic Studies-Dr. E. B.
Singleton, director of radiology, St. Luke's
and Texas Children's Hospitals; associate
professor of radiology, Baylor University
College of Medicine.

FRIDAY-APRIL 23

Unusual Pneumonias-Dr. John P. Jimenez, instructor, division of radiodiagnosis,
department of radiology, MCV.

A.M.
8 : 30-9: 15

11:30-12 : 15

P .M.

9 : 15-10

12 :30- 1:30

Lunch

1 :45-2 :30

Pathology of Congenital H eart Disease with
Emphasis on Embryogenesis-Dr. J. B.
Arey, pathologist, St. Christopher's Hospital for Children; professor of pathology,
Temple University School of Medicine.

2 :30-3 : 15

Plain Film Diagnosis 'in Congenital H eart
Disease-Dr. Lester.

3 : 15- 3:30

Intermission

3:30--4 : 15

Angiocardiographic Diagnosis of Congenital Heart Disease-Dr. Lester.

4 : 15-5

Vascular Rings-Dr. T. Keats, professor
and chairman, department of radiology,
University of Virginia Medical School.
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10-10:30

Gastrointestinal Disorders of the Newborn
-Dr. Platou.
E sophageal Atresia and Tracheoesophageal
Fistula-Dr. Kirkpatrick.

Intermission

10: 30-11 : 15 Intestinal Obstruction in Infants and Children-Dr. Singleton.
11 : 15-12
Malrotation and Fixation of the Bowel:
R adiologic D etection and Clinical Significance-Dr. M. H. Wittenborg, radiologist,
Children's Hospital Medical Center of
Boston; associate clinical professor of radiology, Harvard Medical School.

P.M.
12-1
1-1 :45

Lunch
Pathologic Manifestation of Cystic Fibrosis
of the Pancreas- Dr. Arey.

1 :45-2:30

Roentgen Aspects of Cystic Fibrosis of the
Pancreas-Dr. Wittenborg.

3 : 15

Panel Discussion and Grand Rounds, MCV.

10-10:30

Newer Concepts in Exercise Treatment-Dr.
Paul M. Elwood, Jr., medical director, Sister
Kenny Foundation.

10:30-11

Ultra Sound-What is its Value?-Dr. Justus
F. Lehmann, professor of physical medicine
and rehabilitation, University of Washington
School of Medicine.

11-11 :30

Massage, Manipulation, and Traction in Physical Medicine-Dr. James R. Oates, assistant
professor of physical medicine, Baylor University College of Medicine.

11: 30-12

Thermotherapy-Dr. Edwin L. Lytle, assistant
professor of physical medicine and rehabilitation, MCV.

SATURDAY-APRIL 24

A.M.
8: 30-9: 15

Bony Manifestation of Sickle Cell Disease
and Other Blood Dyscrasias-Dr. Neal.

9: 15-10

Skeletal Maturation, Its Assessment and
Practical Application-Dr. Wittenborg.

10-10: 30

Intermission

10:30-11: 15 Bony Tumors and Tumor-Like Conditions
in Childhood-Dr. Saul Kay, professor and
chairman, division of surgical pathology,
department of pathology, MCV.
11: 15-12

Radiographic Problems About the Knee
and Elbow-Dr. Van Epps.

P.M.
12-12:45

Problem Fractures in Childhood-Dr. M.
J. Hoover, Jr., professor and chairman, division of orthopedic surgery, MCV.

P.M.
12-2

Lunch

2-3

Stoneburner Lecture II-New Developments
in the Field of Biomedical Engineering.

3-3 : 30

Lower Extremity
Prosthetics-Dr.
Roy
Hoover, medical director, Woodrow Wilson
Rehabilitation Center.

3: 30-4

Recent Advances in Upper Extremity Bracing
-Dr. John M. Herring, assistant professor of
physical medicine and rehabilitation, MCV.

4-4:30

Electromyography-Dr. John B. Redford, professor and chairman, department of physical
medicine, MCV.

TUITION

$100 for the entire course, including registration fee, noon
lunches, and one evening dinner. For physicians in residency training, the tuition is $50.
If an enrollment is cancelled in advance, a remittance of

$90 ($40 for resident physicians) will be made. The registration is nontransferable and is made for the entire course.
Separate daily attendance fee is $30, plus $10 for registration.

FRID_'\Y-APRIL 30

A.M.
10-10:30

Wives accompanying their husbands will be guests for
dinner.
For further information, write or call: Dr. M . Pinson Neal,
Jr., Director, Postgraduate Course, Department of Radiology, Medical College of Virginia, Richmond, Va. 23219.
Phone: 703-644-9851.

10: 30-11

Prognosis in Stroke-Dr. Elwood.

11-11: 30

Management of Acute Stage Stroke-Dr. Redford.

11 : 30-12

Management of Chronic Stage Stroke-Dr.
Oates.

APRIL 28-30, 1965

18TH ANNUAL STONEBURNER LECTURE SERIES
AND SYMPOSIUM: REHABILITATION WITH SPECIAL EMPHASIS ON STROKE.
Stoneburner Lecturer

Dr. Frank H. Krusen, professor of
physical medicine and rehabilitation, Temple University School of
Medicine.

P.M.
12-2

Lunch

2-2: 30

Counseling of the Family of the Stroke Patient
- Dr. Henry D . Lederer, chairman, department of psychiatry, MCV.

2: 30-3

Gait Training-Dr. Lehmann.

3-3: 30

The Communication Problem-Mrs. Martha
L. Taylor, director, speech and hearing therapy,
New York University Medical Center.

3: 30-4

Panel on Rehabilitation Problems.

WEDNESDAY-APRIL 28

P.M.
8: 30

Stoneburner Lecture I- R ehabilitation Adds
Life to Years.

THURSDAY-APRIL 29

A.M.
9-10

Registration for Symposium, Egyptian Building, MCV.

The Diagnosis of Cerebrovascular DiseaseDr. Laurie E. Rennie, assistant professor, department of neurology, MCV.

TUITION

$10 per day for the Symposium. There is no charge for
attending Dr. Krusen's lectures.
For further information, write: Dr. John B. Redford, Chairman, Department of Physical Medicine and Rehabilitation,
Medical College of Virginia, Richmond Va. 23219.
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The MEDICAL COLLEGE OF VIRGINIA QUARTERLY is designed
primarily for the postgraduate education of physicians. The QUARTERLY
will publish results of original research in basic and clinical sciences, and
report on seminars and symposiums held at the College. Contributions
from outside the MCV faculty are invited.
Manuscripts, submitted in duplicate, should be prepared according to
recommendations in the Style Manual for Biological Journals , 2nd ed.,
published in 1964 by the American Institute of Biological Sciences, 2000
P Street, N.W., Washington, D . C. 20036.
Correspondence : MEDICAL COLLEGE OF VIRGINIA QUARTERLY, Medical College of Virginia, Richmond , Va. 23219. Phone :
703-644-9851.
Subscription rates in the USA and Canada : 1 year, $4; 2 years, $7;
3 years, $9. All other countries: 1 year, $5; 2 years, $8; 3 years, $10
House staff, medical students, and fellows : 1 year, $2.
Editorial A<lvisory Board

William M. Feagans
Fairfield Goodale, Jr.
June L. Huntley
Richard G . Lester

Hunter H . McGuire, Jr.
Kinloch Nelson
Arnold M. Salzberg
Frederick J. Spencer

EDITOR
Sarni I. Said
Designer, Bruce W. Smith; Photographer, Wirt Christian; Editorial Assistant, Karen Kevorkian .
Printed by the Waverly Press, Baltimore, Md . Entered third class mail at Baltimore,
Md . Copyright 1965 by the Medical Co llege of Virginia.

The Medical Education Building, at the corner of 11th a11d
Marshall Streets, opposite the Medical College Hospital, was
designed by Merrill C. Lee, and completed in 1963. The 10story structure houses offices for faculty and administration,
student laboratories and study areas, research laboratories,
and classrooms equipped with closed circuit television.
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